EIDP (CTA-PA) 10-Q 4 Nov 22 2022 Q3 Quarterly report Financial data

DEI Document

DEI Document - $ / shares	9 Months Ended
	Sep. 30, 2022	Oct. 28, 2022	Dec. 31, 2021	Sep. 30, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Amendment Flag	false
Document Transition Report	false
Entity File Number	001-38710
Entity Registrant Name	Corteva, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4979096
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		714,492,000
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Entity Central Index Key	0001755672
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Current Reporting Status	Yes
Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	CTVA
Security Exchange Name	NYSE
EID [Member]
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Amendment Flag	false
Document Transition Report	false
Entity File Number	1-815
Entity Registrant Name	E. I. du Pont de Nemours and Company
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	51-0014090
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		200
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30	$ 0.30
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Current Reporting Status	Yes
EID [Member] | Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
EID [Member] | $3.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$3.50 Series Preferred Stock
Trading Symbol	CTAPrA
Security Exchange Name	NYSE
EID [Member] | $4.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$4.50 Series Preferred Stock
Trading Symbol	CTAPrB
Security Exchange Name	NYSE

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net Sales	$ 2,777	$ 2,371	$ 13,630	$ 12,176
Cost of Goods Sold	1,879	1,558	7,926	6,988
Research and Development Expense	312	297	876	871
Selling, General and Administrative Expenses	657	672	2,409	2,403
Amortization of Intangibles	178	180	536	543
Restructuring and Asset related charges, net	152	26	300	261
Other income - net	23	378	89	1,013
Interest Expense	18	8	43	22
Income from continuing operations before income taxes	(396)	8	1,629	2,101
Provision for (benefit from) income taxes on continuing operations	(74)	(28)	372	434
Income from continuing operations after income taxes	(322)	36	1,257	1,667
Income (loss) from discontinued operations after income taxes	(6)	(4)	(46)	(59)
Net income	(328)	32	1,211	1,608
Net income attributable to noncontrolling interests	3	2	9	8
Net income attributable to Corteva	$ (331)	$ 30	$ 1,202	$ 1,600
Basic earnings (loss) per share of common stock from continuing operations	$ (0.45)	$ 0.05	$ 1.73	$ 2.25
Basic earnings (loss) per share of common stock from discontinued operations	(0.01)	(0.01)	(0.06)	(0.08)
Basic earnings (loss) per share of common stock	(0.46)	0.04	1.67	2.17
Diluted earnings (loss) per share of common stock from continuing operations	(0.45)	0.05	1.72	2.23
Diluted earnings (loss) per share of common stock from discontinued operations	(0.01)	(0.01)	(0.06)	(0.08)
Diluted earnings (loss) per share of common stock	$ (0.46)	$ 0.04	$ 1.66	$ 2.15
EID [Member]
Net Sales	$ 2,777	$ 2,371	$ 13,630	$ 12,176
Cost of Goods Sold	1,879	1,558	7,926	6,988
Research and Development Expense	312	297	876	871
Selling, General and Administrative Expenses	657	672	2,409	2,403
Amortization of Intangibles	178	180	536	543
Restructuring and Asset related charges, net	152	26	300	261
Other income - net	23	378	89	1,013
Interest Expense	32	19	76	61
Income from continuing operations before income taxes	(410)	(3)	1,596	2,062
Provision for (benefit from) income taxes on continuing operations	(77)	(30)	364	425
Income from Continuing Operations After Taxes	(333)	27	1,232	1,637
Income (loss) from discontinued operations after income taxes	(6)	(4)	(46)	(59)
Net income	(339)	23	1,186	1,578
Net income attributable to noncontrolling interests	0	(1)	1	0
Net income attributable to Corteva	$ (339)	$ 24	$ 1,185	$ 1,578

Consolidated Statements of Comp

Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net income	$ (328)	$ 32	$ 1,211	$ 1,608
Cumulative Translation Adjustments	(533)	(264)	(868)	(424)
Unrealized Gain (Loss) on Investments	0	0	0	10
Derivatives Instruments	50	11	42	107
Total other comprehensive income (loss)	(369)	(400)	(694)	(755)
Comprehensive income (loss)	(697)	(368)	517	853
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	3	2	9	8
Comprehensive Income (Loss) Attributable to Corteva	(700)	(370)	508	845
Pension Plan
Adjustments to benefit plans	113	10	128	26
Other Benefit Plans
Adjustments to benefit plans	1	(157)	4	(474)
EID [Member]
Net income	(339)	23	1,186	1,578
Cumulative Translation Adjustments	(533)	(264)	(868)	(424)
Unrealized Gain (Loss) on Investments	0	0	0	10
Derivatives Instruments	50	11	42	107
Total other comprehensive income (loss)	(369)	(400)	(694)	(755)
Comprehensive income (loss)	(708)	(377)	492	823
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	0	(1)	1	0
Comprehensive Income (Loss) Attributable to Corteva	(708)	(376)	491	823
EID [Member] | Pension Plan
Adjustments to benefit plans	113	10	128	26
EID [Member] | Other Benefit Plans
Adjustments to benefit plans	$ 1	$ (157)	$ 4	$ (474)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Cash and cash equivalents	$ 2,199	$ 4,459	$ 2,779
Marketable Securities	119	86	103
Accounts and notes receivable - net	6,273	4,811	5,818
Inventories	5,415	5,180	4,417
Other current assets	1,039	1,010	1,029
Total current assets	15,045	15,546	14,146
Investments in nonconsolidated affiliates	91	76	67
Property, Plant and Equipment	8,444	8,364	8,270
Less: Accumulated Depreciation	4,259	4,035	3,960
Net Property, Plant and Equipment	4,185	4,329	4,310
Goodwill	9,791	10,107	10,130
Other intangible assets	9,461	10,044	10,225
Deferred Income Taxes	407	438	448
Other assets	1,671	1,804	1,796
Total Assets	40,651	42,344	41,122
Short-term borrowings and finance lease obligations	1,576	17	1,372
Accounts payable	4,140	4,126	3,512
Income Taxes Payable	227	146	95
Deferred Revenue	860	3,201	692
Accrued and other current liabilities	2,115	2,068	2,134
Total current liabilities	8,918	9,558	7,805
Long-term Debt	1,277	1,100	1,101
Deferred income tax liabilities	1,123	1,220	930
Pension and other post employment benefits - noncurrent	2,628	3,124	4,583
Other noncurrent obligations	1,621	1,719	1,724
Total noncurrent liabilities	6,649	7,163	8,338
Common stock	7	7	7
Additional Paid in Capital	27,815	27,751	27,712
Retained earnings	614	524	666
Accumulated other comprehensive income (loss)	(3,592)	(2,898)	(3,645)
Total stockholders' equity attributable to the company	24,844	25,384	24,740
Noncontrolling Interests	240	239	239
Total Equity	25,084	25,623	24,979
Liabilities and Equity	40,651	42,344	41,122
EID [Member]
Cash and cash equivalents	2,199	4,459	2,779
Marketable Securities	119	86	103
Accounts and notes receivable - net	6,273	4,811	5,818
Inventories	5,415	5,180	4,417
Other current assets	1,039	1,010	1,029
Total current assets	15,045	15,546	14,146
Investments in nonconsolidated affiliates	91	76	67
Property, Plant and Equipment	8,444	8,364	8,270
Less: Accumulated Depreciation	4,259	4,035	3,960
Net Property, Plant and Equipment	4,185	4,329	4,310
Goodwill	9,791	10,107	10,130
Other intangible assets	9,461	10,044	10,225
Deferred Income Taxes	407	438	448
Other assets	1,671	1,804	1,796
Total Assets	40,651	42,344	41,122
Short-term borrowings and finance lease obligations	1,576	17	1,372
Accounts payable	4,140	4,126	3,512
Income Taxes Payable	227	146	95
Deferred Revenue	860	3,201	692
Accrued and other current liabilities	2,134	2,070	2,147
Total current liabilities	8,937	9,560	7,818
Long-term Debt	1,277	1,100	1,101
Long Term Debt - Related Party	1,066	2,162	2,443
Deferred income tax liabilities	1,123	1,220	930
Pension and other post employment benefits - noncurrent	2,628	3,124	4,583
Other noncurrent obligations	1,621	1,719	1,724
Total noncurrent liabilities	7,715	9,325	10,781
Common stock	0	0	0
Additional Paid in Capital	24,252	24,196	24,158
Retained earnings	3,098	1,922	1,771
Accumulated other comprehensive income (loss)	(3,592)	(2,898)	(3,645)
Total stockholders' equity attributable to the company	23,997	23,459	22,523
Noncontrolling Interests	2	0	0
Total Equity	23,999	23,459	22,523
Liabilities and Equity	40,651	42,344	41,122
EID [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock	169	169	169
EID [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock	$ 70	$ 70	$ 70

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
Common Stock, Shares Authorized	1,666,667,000	1,666,667,000	1,666,667,000
Common Stock, Shares, Outstanding	716,225,000	726,527,000	730,267,000
EID [Member]
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30
Common Stock, Shares Authorized	1,800,000,000	1,800,000,000	1,800,000,000
Common Stock, Shares, Outstanding	200	200	200
EID [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
EID [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Cash provided by (used for) operating activities
Net income		$ 1,211	$ 1,608
Provision for (benefit from) Deferred Income Tax		(149)	151
Net Periodic Pension and OPEB benefit, net		(155)	(959)
Pension and OPEB Contributions		(147)	(202)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments		(17)	(1)
Restructuring and Asset related charges, net		300	261
Other net loss		181	117
Accounts and notes receivable		(1,814)	(1,116)
Inventories		(466)	375
Accounts Payable		202	(41)
Deferred Revenue		(2,311)	(1,945)
Other Assets and Liabilities		100	7
Cash provided by (used for) operating activities		(2,146)	(819)
Cash provided by (used for) investing activities
Capital expenditures		(460)	(413)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested		46	53
Investments in and loans to nonconsolidated affiliates		(9)	(3)
Purchases of investments		(314)	(147)
Proceeds from Sale and Maturities of Investments		274	310
Other investing activities - net		24	(1)
Cash provided by (used for) investing activities		(439)	(201)
Cash provided by (used for) financing activities
Net change in borrowings (less than 90 days)		777	949
Proceeds from debt		1,335	419
Payments on Debt		(355)	(1)
Repurchase of Common Stock		(800)	(750)
Proceeds from Exercise of Stock Options		66	71
Dividends paid to stockholders		(311)	(295)
Other financing activities		(49)	(28)
Cash provided by (used for) financing activities		663	365
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash		(295)	(78)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash		(2,217)	(733)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period		4,836	3,873
Cash, Cash Equivalents and Restricted Cash at End of Period	[1]	2,619	3,140
EID [Member]
Cash provided by (used for) operating activities
Net income		1,186	1,578
Depreciation and Amortization		919	926
Provision for (benefit from) Deferred Income Tax		(149)	151
Net Periodic Pension and OPEB benefit, net		(155)	(959)
Pension and OPEB Contributions		(147)	(202)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments		(17)	(1)
Restructuring and Asset related charges, net		300	261
Other net loss		181	117
Accounts and notes receivable		(1,814)	(1,116)
Inventories		(466)	375
Accounts Payable		202	(41)
Deferred Revenue		(2,311)	(1,945)
Other Assets and Liabilities		119	18
Cash provided by (used for) operating activities		(2,152)	(838)
Cash provided by (used for) investing activities
Capital expenditures		(460)	(413)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested		46	53
Investments in and loans to nonconsolidated affiliates		(9)	(3)
Purchases of investments		(314)	(147)
Proceeds from Sale and Maturities of Investments		274	310
Other investing activities - net		24	(1)
Cash provided by (used for) investing activities		(439)	(201)
Cash provided by (used for) financing activities
Net change in borrowings (less than 90 days)		777	949
Proceeds from Related Party Debt		19	31
Repayments of Related Party Debt		(1,116)	(1,047)
Proceeds from debt		1,335	419
Payments on Debt		(355)	(1)
Proceeds from Exercise of Stock Options		66	71
Other financing activities		(57)	(38)
Cash provided by (used for) financing activities		669	384
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash		(295)	(78)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash		(2,217)	(733)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period		4,836	3,873
Cash, Cash Equivalents and Restricted Cash at End of Period		2,619	3,140
Total company [Member]
Cash provided by (used for) operating activities
Depreciation and Amortization		919	926
Restructuring and Asset related charges, net		300	261
Total company [Member] | EID [Member]
Cash provided by (used for) operating activities
Depreciation and Amortization		919	926
Restructuring and Asset related charges, net		$ 300	$ 261
[1]See page 16 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Statement of Stockholders Equit

Statement of Stockholders Equity Statement - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comp (Loss) Income	Noncontrolling Interest [Member]	EID [Member]	EID [Member] Preferred Stock [Member]	EID [Member] Common Stock [Member]	EID [Member] Additional Paid-in Capital [Member]	EID [Member] Retained Earnings [Member]	EID [Member] Accumulated Other Comp (Loss) Income	EID [Member] Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2020	$ 25,063	$ 7	$ 27,707	$ 0	$ (2,890)	$ 239	$ 21,601	$ 239	$ 0	$ 24,049	$ 203	$ (2,890)	$ 0
Net income (loss)	603			600		3	592				591		1
Other comprehensive (loss) income	(477)				(477)		(477)					(477)
Common Dividends	(97)		(97)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	38		38				38			38
Repurchase of common stock	(350)		(18)	(332)
Other-net	(2)					(2)	(4)			(4)
Ending Balance at Mar. 31, 2021	24,778	7	27,630	268	(3,367)	240	21,748	239	0	24,083	792	(3,367)	1
Beginning Balance at Dec. 31, 2020	25,063	7	27,707	0	(2,890)	239	21,601	239	0	24,049	203	(2,890)	0
Net income (loss)	1,608						1,578
Other comprehensive (loss) income	(755)				(755)		(755)
Ending Balance at Sep. 30, 2021	24,979	7	27,712	666	(3,645)	239	22,523	239	0	24,158	1,771	(3,645)	0
Beginning Balance at Mar. 31, 2021	24,778	7	27,630	268	(3,367)	240	21,748	239	0	24,083	792	(3,367)	1
Net income (loss)	973			970		3	963				963
Other comprehensive (loss) income	122				122		122					122
Common Dividends	(95)			(95)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	28		28				28			28
Share-based compensation	22		23	(1)			22			23	(1)
Repurchase of common stock	(200)			(200)
Other-net	(3)		1	(1)		(3)	(2)			(3)	1
Ending Balance at Jun. 30, 2021	25,625	7	27,682	941	(3,245)	240	22,878	239	0	24,131	1,752	(3,245)	1
Net income (loss)	32			30		2	23				24		(1)
Other comprehensive (loss) income	(400)				(400)		(400)					(400)
Common Dividends	(103)			(103)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	5		5				5			5
Share-based compensation	25		26	(1)			25			26	(1)
Repurchase of common stock	(200)			(200)
Other-net	(5)		(1)	(1)		(3)	(6)			(4)	(2)
Ending Balance at Sep. 30, 2021	24,979	7	27,712	666	(3,645)	239	22,523	239	0	24,158	1,771	(3,645)	0
Beginning Balance at Dec. 31, 2021	25,623	7	27,751	524	(2,898)	239	23,459	239	0	24,196	1,922	(2,898)	0
Net income (loss)	567			564		3	560				559		1
Other comprehensive (loss) income	77				77		77					77
Common Dividends	(102)			(102)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	40		40				40			40
Share-based compensation	(31)		(31)				(31)			(31)
Repurchase of common stock	(235)			(235)
Other-net	(3)			(1)		(2)	(4)			(3)	(1)
Ending Balance at Mar. 31, 2022	25,936	7	27,760	750	(2,821)	240	24,099	239	0	24,202	2,478	(2,821)	1
Beginning Balance at Dec. 31, 2021	25,623	7	27,751	524	(2,898)	239	23,459	239	0	24,196	1,922	(2,898)	0
Net income (loss)	1,211						1,186
Other comprehensive (loss) income	(694)				(694)		(694)
Ending Balance at Sep. 30, 2022	25,084	7	27,815	614	(3,592)	240	23,999	239	0	24,252	3,098	(3,592)	2
Beginning Balance at Mar. 31, 2022	25,936	7	27,760	750	(2,821)	240	24,099	239	0	24,202	2,478	(2,821)	1
Net income (loss)	972			969		3	965				965
Other comprehensive (loss) income	(402)				(402)		(402)					(402)
Common Dividends	(101)			(101)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	22		22				22			22
Share-based compensation	12		13	(1)			12			13	(1)
Repurchase of common stock	(365)			(365)
Other-net	(3)					(3)	(2)			(2)
Ending Balance at Jun. 30, 2022	26,071	7	27,795	1,252	(3,223)	240	24,691	239	0	24,235	3,439	(3,223)	1
Net income (loss)	(328)			(331)		3	(339)				(339)
Other comprehensive (loss) income	(369)				(369)		(369)					(369)
Common Dividends	(108)			(108)
Dividends, Preferred Stock							(2)				(2)
Issuance of Corteva Stock	4		4				4			4
Share-based compensation	15		16	(1)			15			16	(1)
Repurchase of common stock	(200)			(200)
Other-net	(1)			2		(3)	(1)			(3)	1		1
Ending Balance at Sep. 30, 2022	$ 25,084	$ 7	$ 27,815	$ 614	$ (3,592)	$ 240	$ 23,999	$ 239	$ 0	$ 24,252	$ 3,098	$ (3,592)	$ 2

Statement of Stockholders' Equi

Statement of Stockholders' Equity Parentheticals (Parentheticals) - $ / shares	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Common Stock, Dividends, Per Share, Declared	$ 0.15	$ 0.14	$ 0.14	$ 0.14	$ 0.13	$ 0.13
EID [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared							$ 1.125	$ 1.125
EID [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared							$ 0.875	$ 0.875

Summary of Significant Accounti

Summary of Significant Accounting Policies (Notes)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2021, collectively referred to as the “2021 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 5 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 9 – Supplemental Information, to the company's 2021 Annual Report). As of September 30, 2022, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million. We will continue to assess the implications to our operations and financial reporting. In April 2022, the company implemented a global business unit organization model (“BU Reorganization”). While the new organization model had no impact on our determination of operating segments, it did result in the company’s digital reporting unit being merged into the seed and crop protection reporting units with the goodwill relating to the former digital reporting unit being reassigned to the seed and crop protection reporting units using a relative fair value allocation approach. The impact of the BU Reorganization did not have a material impact to the company’s historical reportable segments’ financial measures. An interim goodwill impairment assessment immediately prior to the BU Reorganization and for the seed and crop protection reporting units immediately after the BU Reorganization resulted in no goodwill impairment charges. Qualitative impairment assessments were performed for the seed and crop protection reporting units. The qualitative assessments included an evaluation of relevant factors including GDP growth rates, long-term commodity prices, equity and credit market activity, discount rates, changes in the industry and market structure, competitive environments, cost factors such as raw material prices, and overall financial performance. Based on the qualitative assessments performed, it was more likely than not that the fair value of each reporting unit exceeded the carrying value and therefore a quantitative test was not performed . A quantitative impairment assessment was performed for the former digital reporting unit using a combination of the discounted cash flow model (a form of the income approach) and the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis included future cash flow projections, weighted average cost of capital, the terminal growth rate and the tax rate. The company’s estimate of future cash flows is based on current regulatory and economic climates, recent operating results, and assumed business strategy from a market participant perspective and includes an estimate of a long-term future growth rate based on such strategy. Actual results may differ from those assumed in the company’s forecast. The company derives its discount rate using a capital asset pricing model and analyzes published rates for industries relevant to its reporting unit to estimate the cost of equity financing. The company uses a discount rate that is commensurate with the risks and uncertainty inherent in the reporting unit and in its internally developed forecast. Under the market approach, the company uses historically completed transactions for comparable companies.

Recent Accounting Guidance

Recent Accounting Guidance	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, which requires business entities to disclose transactions with a governmental entity for which a grant or contribution accounting model is used in recognizing and measuring such transactions. This standard is effective for fiscal years beginning after December 15, 2021, and early adoption is permitted. The company adopted this guidance on January 1, 2022 and it did not have a material impact on the company’s disclosures. Accounting Guidance Issued But Not Adopted as of September 30, 2022 In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. This ASU includes amendments that require a buyer in supplier finance programs to disclose key terms of the programs and related obligations, including a rollforward of such obligations. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the rollforward requirements, which is effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. Retrospective application to all periods in which a balance sheet is presented is required, except for the rollforward requirement, which will be applied prospectively. The adoption of this guidance will result in the company being required to include certain disclosures relating to supplier financing programs and related obligations.

Revenue (Notes)

Revenue (Notes)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer	REVENUE Revenue Recognition Products Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years. Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less. The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances. Licenses of Intellectual Property Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied. Remaining Performance Obligations Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $129 million, $123 million and $122 million at September 30, 2022, December 31, 2021 and September 30, 2021, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of one year to six years. Contract Balances Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract Balances September 30, 2022 December 31, 2021 September 30, 2021 (In millions) Accounts and notes receivable - trade 1 $ 4,875 $ 3,561 $ 4,744 Contract assets - current 2 $ 25 $ 24 $ 24 Contract assets - noncurrent 3 $ 62 $ 58 $ 60 Deferred revenue - current $ 860 $ 3,201 $ 692 Deferred revenue - noncurrent 4 $ 108 $ 120 $ 111 1. Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets. 2. Included in other current assets in the interim Consolidated Balance Sheets. 3. Included in other assets in the interim Consolidated Balance Sheets. 4. Included in other noncurrent obligations in the interim Consolidated Balance Sheets. Revenue recognized during the nine months ended September 30, 2022 and 2021 from amounts included in deferred revenue at the beginning of the period was $3,049 million and $2,454 million, respectively. Disaggregation of Revenue Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below: Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Corn $ 469 $ 437 $ 4,621 $ 4,505 Soybean 205 157 1,685 1,494 Other oilseeds 124 94 647 661 Other 64 50 380 350 Seed 862 738 7,333 7,010 Herbicides 1,043 782 3,472 2,737 Insecticides 363 416 1,275 1,261 Fungicides 421 339 1,173 911 Other 88 96 377 257 Crop Protection 1,915 1,633 6,297 5,166 Total $ 2,777 $ 2,371 $ 13,630 $ 12,176 Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below: Seed Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 North America 1 $ 218 $ 168 $ 4,637 $ 4,482 EMEA 2 157 153 1,442 1,398 Latin America 383 334 912 842 Asia Pacific 104 83 342 288 Total $ 862 $ 738 $ 7,333 $ 7,010 Crop Protection Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 North America 1 $ 521 $ 422 $ 2,185 $ 1,693 EMEA 2 297 237 1,452 1,304 Latin America 898 763 1,852 1,361 Asia Pacific 199 211 808 808 Total $ 1,915 $ 1,633 $ 6,297 $ 5,166 1. Represents U.S. & Canada. 2. Europe, Middle East, and Africa ("EMEA").

Restructuring and Asset Related

Restructuring and Asset Related Charges	9 Months Ended
	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	RESTRUCTURING AND ASSET RELATED CHARGES - NET 2022 Restructuring Actions In connection with the company’s shift to a global business unit model, the company has assessed its business priorities and operational structure to maximize the customer experience and deliver on growth and earnings potential. As a result of this assessment, the company has committed to restructuring actions that, combined with the impact of the company’s separate announcement to withdraw from Russia (“Russia Exit”) (collectively the “2022 Restructuring Actions”), is expected to result in total net pre-tax restructuring and other charges of $350 million to $420 million comprised of $105 million to $120 million of severance and related benefit costs, $155 million to $180 million of asset related charges, $65 million to $80 million of costs related to contract terminations (contract terminations includes early lease terminations) and $25 million to $40 million of other charges. Future cash payments related to these charges are anticipated to be $150 million to $175 million, primarily related to the payment of severance and related benefits, contract terminations and other charges. The restructuring actions associated with these charges are expected to be substantially complete in 2023. The total net pre-tax restructuring and other charges included $47 million associated with the Russia Exit for the nine months ended September 30, 2022. The Russia Exit net pre-tax restructuring charges consisted of $6 million of severance and related benefit costs, $3 million of asset related charges, and $28 million of costs related to contract terminations (contract terminations includes early lease terminations). The company also recorded other pre-tax charges associated with the Russia Exit to cost of goods sold and other income – net in the interim Consolidated Statement of Operations, relating to inventory write-offs of $2 million and settlement costs of $8 million, respectively. Additional pre-tax charges up to $20 million associated with the Russia Exit are possible, primarily associated with government receivables. The charges related to the 2022 Restructuring Actions related to the segments, as well as corporate expenses, for the three and nine months ended September 30, 2022 were as follows: Three Months Ended September 30, Nine Months Ended (In millions) 2022 2022 Seed $ 61 $ 94 Crop Protection 19 20 Corporate expenses 66 88 Total 1 $ 146 $ 202 1. This amount excludes the pre-tax charges impacting Seed recorded to cost of goods sold and other income - net in the company's interim Consolidated Statement of Operations, relating to inventory write-offs of $33 million, and a gain on sale of a business of $15 million, settlement costs associated with the Russia Exit, and charges associated with the exit of a non-strategic asset of $5 million, respectively. The following table is a summary of charges incurred related to 2022 Restructuring Actions for the three and nine months ended September 30, 2022: Three Months Ended September 30, Nine Months Ended (In millions) 2022 2022 Severance and related benefit costs $ 66 $ 88 Asset related charges 66 70 Contract termination charges 1 14 44 Total restructuring and asset related charges - net 2 $ 146 $ 202 1. Contract terminations includes early lease terminations. 2. This amount excludes the pre-tax charges recorded to the cost of goods sold and other income - net in the interim Consolidated Statement of Operations, relating to inventory write-offs of $33 million, and a gain on sale of a business of $15 million, settlement costs associated with the Russia Exit and charges associated with the exit of a non-strategic asset of $5 million, respectively. A reconciliation of the December 31, 2021 to the September 30, 2022 liability balances related to the 2022 Restructuring Actions is summarized below: (in millions) Severance and Related Benefit Costs Asset Related Contract Termination 1 Total Balance at December 31, 2021 $ — $ — $ — $ — Charges to income (loss) from continuing operations 88 70 44 202 Payments (19) — (5) (24) Asset write-offs — (70) — (70) Balance at September 30, 2022 $ 69 $ — $ 39 $ 108 1. The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022. 2021 Restructuring Actions During the first quarter of 2021, Corteva approved restructuring actions designed to right-size and optimize its footprint and organizational structure according to the business needs in each region with the focus on driving continued cost improvement and productivity. Through the third quarter of 2022, the company recorded net pre-tax restructuring charges of $166 million inception-to-date under the 2021 Restructuring Actions, consisting of $77 million of severance and related benefit costs, $44 million of asset related charges, $6 million of asset retirement obligations and $39 million of costs related to contract terminations (contract terminations includes early lease terminations). The company does not anticipate any additional material charges from the 2021 Restructuring Actions as actions associated with this charge were substantially complete by the end of 2021. The charges related to the 2021 Restructuring Actions related to the segments, as well as corporate expenses, for the three and nine months ended September 30, 2022 and 2021 were as follows: Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Seed $ 1 $ 4 $ (1) $ 21 Crop Protection (1) 4 (3) 41 Corporate expenses — 9 3 65 Total $ — $ 17 $ (1) $ 127 The following table is a summary of charges incurred related to 2021 Restructuring Actions for the three and nine months ended September 30, 2022 and 2021: Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Severance and related benefit costs $ — $ 9 $ 3 $ 58 Asset related charges — 7 (1) 29 Contract termination charges — 1 (3) 40 Total restructuring and asset related charges - net $ — $ 17 $ (1) $ 127 A reconciliation of the December 31, 2021 to the September 30, 2022 liability balances related to the 2021 Restructuring Actions is summarized below: (In millions) Severance and Related Benefit Costs Asset Related 1 Contract Termination Total Balance at December 31, 2021 $ 52 $ — $ 12 $ 64 Charges to income (loss) from continuing operations 3 (1) (3) (1) Payments (35) — (8) (43) Asset write-offs — 1 — 1 Balance at September 30, 2022 $ 20 $ — $ 1 $ 21 1. In addition, the company has a liability recorded for asset retirement obligations of $3 million as of September 30, 2022. Other Asset Related Charges The company recognized $5 million and $104 million for the three and nine months ended September 30, 2022, respectively, and $5 million and $124 million for the three and nine months ended September 30, 2021, respectively, in restructuring and asset related charges - net in the interim Consolidated Statement of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

Supplementary Information

Supplementary Information	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Additional Financial Information Disclosure [Text Block]	SUPPLEMENTARY INFORMATION Other Income - Net Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Interest income $ 36 $ 19 $ 75 $ 58 Equity in earnings (losses) of affiliates - net (1) (1) 13 4 Net gain (loss) on sales of businesses and other assets 16 1 17 2 Net exchange gains (losses) 1 (13) 2 (96) (47) Non-operating pension and other post employment benefit credit (costs) 2 22 326 170 979 Miscellaneous income (expenses) - net 3 (37) 31 (90) 17 Other income - net $ 23 $ 378 $ 89 $ 1,013 1. Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively. 2. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 3. Miscellaneous income (expenses) - net for the three and nine months ended September 30, 2022 and 2021 includes losses on sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. Miscellaneous income (expenses) - net for the three and nine months ended September 30, 2022 also includes estimated settlement reserves, settlement cost associated with the Russia Exit and an Employee Retention Credit, and the nine months ended September 30, 2022 also includes charges associated with the exit of a non-strategic asset. Additionally, the three and nine months ended September 30, 2021 includes a gain from remeasurement of an equity investment and the nine months ended September 30, 2021 includes realized losses on sale of available-for-sale securities. The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statements of Operations. (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Subsidiary Monetary Position Gain (Loss) Pre-tax exchange gain (loss) $ (80) $ (32) $ (120) $ (47) Local tax (expenses) benefits (40) 3 (61) (11) Net after-tax impact from subsidiary exchange gain (loss) $ (120) $ (29) $ (181) $ (58) Hedging Program Gain (Loss) Pre-tax exchange gain (loss) $ 67 $ 34 $ 24 $ — Tax (expenses) benefits (15) (8) (5) — Net after-tax impact from hedging program exchange gain (loss) $ 52 $ 26 $ 19 $ — Total Exchange Gain (Loss) Pre-tax exchange gain (loss) $ (13) $ 2 $ (96) $ (47) Tax (expenses) benefits (55) (5) (66) (11) Net after-tax exchange gain (loss) $ (68) $ (3) $ (162) $ (58) Cash, cash equivalents and restricted cash equivalents The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the interim Consolidated Balance Sheets. (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Cash and cash equivalents $ 2,199 $ 4,459 $ 2,779 Restricted cash equivalents 420 377 361 Total cash, cash equivalents and restricted cash equivalents $ 2,619 $ 4,836 $ 3,140

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	INCOME TAXES For periods between the Merger and the Corteva Distribution, Corteva and its subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year was apportioned among the members of the consolidated group based on each member’s separate taxable income. Corteva, DuPont and Dow intend that to the extent Federal and/or State corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax matters agreement. See Note 12 - Commitments and Contingent Liabilities, for further information related to indemnifications between Corteva, DuPont and Dow. Each year the company files hundreds of tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the company. As a result, there is an uncertainty in income taxes recognized in the company's financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the company's results of operations. During the three and nine months ended September 30, 2022, the company recognized a tax benefit of $55 million to provision for income taxes on continuing operations related to the impact of a change in a U.S. legal entity's tax characterization, resulting in the establishment of deferred taxes. During the three months ended September 30, 2022, the company recognized $9 million of net tax charges to provision for income taxes on continuing operations associated with changes in accruals and deferred taxes for certain prior year tax positions and valuation allowances, partially offset by tax benefits associated with U.S. state tax rate changes. During the nine months ended September 30, 2022, the company recognized $39 million of net tax benefits to provision for income taxes on continuing operations associated with changes in accruals and deferred taxes for certain prior year tax positions in various jurisdictions, U.S state tax rate changes, and stock-based compensation, partially offset by changes in valuation allowances. During the three and nine months ended September 30, 2021, the company recognized $32 million and $58 million, respectively, of net tax benefits to provision for income taxes on continuing operations associated with changes in accruals for certain prior year tax positions in various jurisdictions, including a $22 million tax benefit associated with U.S. research and development credits. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 5 - Supplementary Information. On August 16, 2022, the U.S. federal government enacted the Inflation Reduction Act of 2022 (“the Act”). The Act includes tax provisions, among other things, which implements (i) a 15 percent minimum tax on book income of certain large corporations; (ii) a one percent excise tax on net stock repurchases; and (iii) several tax incentives to promote clean energy. The company does not expect the Act to have a material impact on the company’s financial position, results of operations or cash flows.

Earnings Per Share (Notes)

Earnings Per Share (Notes)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE OF COMMON STOCK The following tables provide earnings per share calculations for the periods indicated below: Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (322) $ 36 $ 1,257 $ 1,667 Net income (loss) attributable to continuing operations noncontrolling interests 3 2 9 8 Income (loss) from continuing operations available to Corteva common stockholders (325) 34 1,248 1,659 (Loss) income from discontinued operations available to Corteva common stockholders (6) (4) (46) (59) Net income (loss) available to common stockholders $ (331) $ 30 $ 1,202 $ 1,600 Earnings (Loss) Per Share Calculations - Basic Three Months Ended Nine Months Ended (Dollars per share) 2022 2021 2022 2021 Earnings (loss) per share of common stock from continuing operations $ (0.45) $ 0.05 $ 1.73 $ 2.25 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) (0.06) (0.08) Earnings (loss) per share of common stock $ (0.46) $ 0.04 $ 1.67 $ 2.17 Earnings (Loss) Per Share Calculations - Diluted Three Months Ended Nine Months Ended (Dollars per share) 2022 2021 2022 2021 Earnings (loss) per share of common stock from continuing operations $ (0.45) $ 0.05 $ 1.72 $ 2.23 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) (0.06) (0.08) Earnings (loss) per share of common stock $ (0.46) $ 0.04 $ 1.66 $ 2.15 Share Count Information Three Months Ended Nine Months Ended (Shares in millions) 2022 2021 2022 2021 Weighted-average common shares - basic 718.7 733.8 722.8 738.1 Plus dilutive effect of equity compensation plans 1 — 5.7 3.6 5.9 Weighted-average common shares - diluted 718.7 739.5 726.4 744.0 Potential shares of common stock excluded from EPS calculations 2 6.1 3.0 2.2 3.1 1. Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. 2. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable (

Accounts and Notes Receivable (Notes)	9 Months Ended
	Sep. 30, 2022
Accounts and Notes Receivable [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	ACCOUNTS AND NOTES RECEIVABLE - NET (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Accounts receivable – trade 1 $ 3,642 $ 3,441 $ 3,336 Notes receivable – trade 1,2 1,233 120 1,408 Other 3 1,398 1,250 1,074 Total accounts and notes receivable - net $ 6,273 $ 4,811 $ 5,818 1. Accounts receivable – trade and notes receivable - trade are net of allowances of $213 million at September 30, 2022, and $210 million at December 31, 2021, and September 30, 2021. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method. 2. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2022, December 31, 2021, and September 30, 2021 there were no significant impairments related to current loan agreements. 3. Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $132 million, $104 million, and $84 million as of September 30, 2022, December 31, 2021, and September 30, 2021, respectively. Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets. The following table summarizes changes in the allowance for doubtful receivables for the three months ended September 30, 2022 and 2021: (In millions) 2021 Balance at December 31, 2020 $ 208 Net benefit for credit losses (7) Write-offs charged against allowance / other 9 Balance at September 30, 2021 $ 210 2022 Balance at December 31, 2021 $ 210 Net provision for credit losses 4 Write-offs charged against allowance / other (1) Balance at September 30, 2022 $ 213 The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Consolidated Balance Sheets. Trade receivables sold under these agreements were $35 million and $130 million for the three and nine months ended September 30, 2022 and $70 million and $257 million for the three and nine months ended September 30, 2021, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of September 30, 2022, December 31, 2021, and September 30, 2021 were $47 million, $166 million, and $173 million, respectively. The net proceeds received are included in cash provided by (used for) operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income - net in the interim Consolidated Statements of Operations. The loss on sale of receivables for the three and nine months ended September 30, 2022 was $6 million and $19 million, and $11 million and $54 million for the three and nine months ended September 30, 2021, respectively. See Note 12 - Commitments and Contingent Liabilities for additional information on the company’s guarantees.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	INVENTORIES (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Finished products $ 2,082 $ 2,497 $ 1,871 Semi-finished products 2,557 2,076 2,028 Raw materials and supplies 776 607 518 Total inventories $ 5,415 $ 5,180 $ 4,417

Other Intangible Assets

Other Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	OTHER INTANGIBLE ASSETS The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Gross Accumulated Net Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization (Definite-lived): Germplasm $ 6,265 $ (762) $ 5,503 $ 6,265 $ (571) $ 5,694 $ 6,265 $ (507) $ 5,758 Customer-related 1,890 (550) 1,340 1,953 (487) 1,466 1,956 (460) 1,496 Developed technology 1,485 (790) 695 1,485 (679) 806 1,485 (641) 844 Trademarks/trade names 2,006 (231) 1,775 2,012 (172) 1,840 2,012 (152) 1,860 Favorable supply contracts 475 (467) 8 475 (396) 79 475 (373) 102 Other 1 395 (265) 130 405 (256) 149 407 (252) 155 Total other intangible assets with finite lives 12,516 (3,065) 9,451 12,595 (2,561) 10,034 12,600 (2,385) 10,215 Intangible assets not subject to amortization (Indefinite-lived): IPR&D 10 — 10 10 — 10 10 — 10 Total other intangible assets 10 — 10 10 — 10 10 — 10 Total $ 12,526 $ (3,065) $ 9,461 $ 12,605 $ (2,561) $ 10,044 $ 12,610 $ (2,385) $ 10,225 1. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements. The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $178 million and $536 million for the three and nine months ended September 30, 2022, respectively and $180 million and $543 million for the three and nine months ended September 30, 2021, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2022 and each year of the next five years is approximately $164 million, $616 million, $602 million, $565 million, $554 million and $494 million, respectively.

Short-Term Borrowings, Long-Ter

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES The following tables summarize Corteva's short-term borrowings and finance lease obligations and long-term debt: Short-term borrowings and finance lease obligations (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Commercial paper $ 1,369 $ — $ 802 Repurchase facility 200 — 550 Other loans - various currencies 6 15 18 Long-term debt payable within one year — 1 1 Finance lease obligations payable within one year 1 1 1 Total short-term borrowings and finance lease obligations $ 1,576 $ 17 $ 1,372 Long-term debt (in millions) September 30, 2022 December 31, 2021 September 30, 2021 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Other loans: Foreign currency loans, various rates and maturities 176 14.80 % 1 6.82 % 1 6.38 % Medium-term notes, varying maturities through 2041 107 2.87 % 107 — % 108 — % Finance lease obligations 2 3 3 Less: Unamortized debt discount and issuance costs 8 10 10 Less: Long-term debt due within one year — 1 1 Total long-term debt $ 1,277 $ 1,100 $ 1,101 The estimated fair value of the company's short-term and long-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations was approximately carrying value. The fair value of the company’s long-term borrowings, including debt due within one year, was $1,154 million, $1,121 million, and $1,134 million as of September 30, 2022, December 31, 2021, and September 30, 2021, respectively. Repurchase Facility In February 2022, the company entered into a new committed receivable repurchase facility of up to $500 million (the "2022 Repurchase Facility") which expires in December 2022. Under the 2022 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2022 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2022 Repurchase Facility have an interest rate equal to the Adjusted Term Secured Overnight Financing Rate ("SOFR"), which is Term SOFR plus 0.10 percent, plus the margin. As of September 30, 2022, $210 million of notes receivable, recorded in accounts and notes receivable - net in the interim Consolidated Balance Sheets, were pledged as collateral against outstanding borrowings under the 2022 Repurchase Facility of $200 million, recorded in short-term borrowings and finance lease obligations in the interim Consolidated Balance Sheets. Foreign Currency Loans The company enters into short-term and long-term foreign currency loans from time-to-time by accessing uncommitted revolving credit lines to fund working capital needs of foreign subsidiaries in the normal course of business (“Foreign Currency Loans”). Interest rates are variable and determined at the time of borrowing. Total unused bank credit lines on the Foreign Currency Loans at September 30, 2022 was approximately $85 million. The company’s long-term Foreign Currency Loans have varying maturities through 2024. Available Committed Credit Facilities The following table summarizes the company's credit facilities: Committed and Available Credit Facilities at September 30, 2022 (in millions) Effective Date Committed Credit Credit Available Maturity Date Interest Revolving Credit Facility May 2022 $ 3,000 $ 3,000 May 2027 Floating Rate Revolving Credit Facility May 2022 2,000 2,000 May 2025 Floating Rate 364-day Revolving Credit Facility May 2022 500 500 May 2023 Floating Rate Total Committed and Available Credit Facilities $ 5,500 $ 5,500 Revolving Credit Facilities In November 2018, EID entered into a $3 billion, 5-year revolving credit facility and a $3 billion, 3-year revolving credit facility (the “Revolving Credit Facilities”). The Revolving Credit Facilities became effective in May 2019. Corteva, Inc. became a party at the time of the Corteva Distribution. In May 2021, the company entered into an amendment that extended the maturity date of the 3-year revolving credit facility from May 2022 to May 2023. Other than the change in maturity date, there were no material modifications to the terms of the credit facility. During May 2022, the Credit Facilities were refinanced for purposes of extending the maturity dates to 2027 and 2025 for the 5-year and 3-year revolving credit facilities, respectively, lowering the facility amount of the 3-year revolving credit facility to $2 billion and transitioning the interest rate to Adjusted Term SOFR, which is Term SOFR plus 0.10 percent, plus the applicable margin. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At September 30, 2022, the company was in compliance with these covenants. 364-day Revolving Credit Facilities In May 2022, the company entered into a $500 million, 364-day revolving credit agreement (the “364-day Revolving Credit Facility”) expiring in May 2023. Borrowings under the 364-day Revolving Credit Facility will have an interest rate equal to Adjusted Term SOFR, which is Term SOFR plus 0.10 percent, plus the applicable margin. The 364-day Revolving Credit Facility includes a provision under which the company may convert any advances outstanding prior to the maturity date into term loans having a maturity date up to one year later. The 364-day Revolving Credit Facility will be used for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The 364-day Revolving Credit Facility contains customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the 364-day Revolving Credit Facility contains a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At September 30, 2022, the company was in compliance with these covenants.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS AND CONTINGENT LIABILITIES Guarantees Indemnifications In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement. Obligations for Customers and Other Third Parties The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At September 30, 2022, December 31, 2021 and September 30, 2021, the company had directly guaranteed $79 million, $105 million, and $107 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. All of the maximum future payments at September 30, 2022 had terms less than one year. The maximum future payments include $19 million, $21 million and $22 million at September 30, 2022, December 31, 2021 and September 30, 2021, respectively, of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables. See Note 8 - Accounts and Notes Receivable - Net, to the interim Consolidated Financial Statements, for additional information. The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $560 million, $15 million and $615 million at September 30, 2022, December 31, 2021 and September 30, 2021, respectively. The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used. Indemnifications under Separation Agreements The company has entered into various agreements where the company is indemnified for certain liabilities. The term of this indemnification is generally indefinite, with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. Chemours/Performance Chemicals Pursuant to the Chemours Separation Agreement resulting from the 2015 spin-off of the Performance Chemicals segment from Historical DuPont, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. In 2017, the Chemours Separation Agreement was amended to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EID settled multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the performance chemicals segment of EID and is now owned and/or operated by Chemours. On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EID, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims proceeded (the “Arbitration”). On January 22, 2021, Chemours, DuPont, Corteva and EID entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances ("PFAS") liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of the escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%. In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account ("MOU Escrow Account"). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029 pursuant to the escrow account replenishment terms as set forth in the MOU. The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Starting with year six, withdrawals can only be made to fund qualified spend if the parties’ aggregate qualified spend in that particular year is greater than $200 million. Beginning with year 11, the amounts in the MOU Escrow Account can be used to fund any qualified spend. The company made its annual installment deposits due to the MOU Escrow Account through September 30, 2022. These payments are classified as noncurrent restricted cash equivalents and included in other assets in the interim Consolidated Balance Sheets. After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties will dismiss the Pending Arbitration regarding those claims. Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU. Corteva Separation Agreement On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow assets, employees, certain liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the parties and provides for indemnification obligation among the parties. Under the Corteva Separation Agreements, DuPont will indemnify Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution and Dow indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that relate to the Historical Dow business, and Corteva indemnifies DuPont and Dow for certain liabilities. Under the Corteva Separation Agreement, certain legacy EID liabilities from discontinued and/or divested operations and businesses of EID (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva (which may include a specified amount of liability associated with that liability), Corteva is responsible for liabilities in an amount up to that specified amount plus an additional $200 million and, for those stray liabilities allocated to DuPont (which may include a specified amount of liability associated with that liability), DuPont is responsible for liabilities up to a specified amount plus an additional $200 million. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont will manage such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold is met, then the companies will share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement. During the second quarter of 2021, the aggregate amount of the company’s cash spent and liabilities accrued exceeded the stray liability thresholds, including PFAS, noted above. Therefore, liabilities recognized subsequent to the second quarter of 2021 are shared at the reduced rates noted above. At September 30, 2022, December 31, 2021, and September 30, 2021, the indemnification assets were $33 million, $25 million, and $25 million, respectively, within accounts and notes receivable - net and $91 million, $75 million, and $70 million, respectively, within other assets in the interim Consolidated Balance Sheets. At September 30, 2022, December 31, 2021, and September 30, 2021, the indemnification liabilities were $24 million, $20 million, and $54 million, respectively, within accrued and other current liabilities and $122 million, $117 million, and $90 million, respectively, within other noncurrent obligations in the interim Consolidated Balance Sheets. Litigation The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EID businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Accruals may reflect the impact and status of negotiations, settlements, rulings, advice from counsel and other information and events that may pertain to a particular matter. For the litigation matters discussed below, management believes that it is reasonably possible that the company could incur liabilities in excess of amounts accrued, the ultimate liability for which could be material to the results of operations and the cash flows in the period recognized. However, the company is unable to estimate the possible loss beyond amounts accrued due to various reasons, including, among others, that the underlying matters are either in early stages and/or have significant factual issues to be resolved. In addition, even when the company believes it has substantial defenses, the company may consider settlement of matters if it believes it is in the best interest of the company. Lorsban ® Lawsuits As of September 30, 2022, there were pending personal injury lawsuits filed and additional asserted claims against the former Dow Agrosciences LLC, alleging injuries related to chlorpyrifos exposure, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Chlorpyrifos products are restricted-use pesticides, which are not available for purchase or use by the general public, and may only be sold to, and used by, certified applicators or someone under the certified applicator's direct supervision. These lawsuits do not relate to Dursban®, a residential type chlorpyrifos product that was authorized for indoor purposes, which was discontinued over two decades ago prior to the Merger and Corteva’s formation and Separation. Claimants allege personal injury, including autism, developmental delays and/or decreased neurologic function, resulting from farm worker exposure and bystander drift and in utero exposure to chlorpyrifos. Certain claimants have also put forth remediation claims due to alleged property contamination from chlorpyrifos. As of September 30, 2022, an accrual has been established for the estimated resolution of certain claims. Litigation related to legacy EID businesses unrelated to Corteva’s current businesses PFAS, PFOA, PFOS and Other Related Liabilities For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs"). EID is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective. Leach Settlement and Ohio MDL Settlement EID has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EID, which alleged that PFOA from EID’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EID to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of September 30, 2022, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million. The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for $670.7 million in cash, with Chemours and EID (without indemnification from Chemours) each paying half. Post-MDL Settlement PFOA Personal Injury Claims The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. The first was a consolidated trial of two cases; the first, a kidney cancer case, which resulted in a hung jury, while the second, Travis and Julie Abbot v. E.I du Pont de Nemours and Company (the “Abbot Case”), a testicular cancer case, resulted in a jury verdict of $40 million in compensatory damages and $10 million for loss of consortium. The loss of consortium award was subsequently reduced to $250,000 in accordance with state law limitations. Following entry of the judgment by the court, EID filed post-trial motions to reduce the verdict, and to appeal the verdict on the basis of procedural and substantive legal errors made by the trial court. The company believes the merits of the appeal will be successful in reducing the jury verdict or eliminating its liability, in whole or part. In January 2021, Chemours, DuPont and Corteva agreed to settle the remaining approximately 95 matters, as well as unfiled matters, remaining in the Ohio MDL, with the exception of the Abbot case, for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company paid $27 million during the year ended December 31, 2021. As agreed to in the settlement, the plaintiffs' counsel filed a motion to dissolve the MDL. EID has sought dissolution of the MDL from the judicial oversight panel responsible for the MDL. Other PFOA Matters EID is a party to other PFOA lawsuits involving claims for property damage, medical monitoring and personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EID would prevail on the merits of these claims. New York . EID is a defendant in about 45 lawsuits, including a putative class action (the "Baker Class Action"), brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring, property damage and personal injury based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls. The lawsuits allege that EID and others supplied materials used at these facilities resulting in PFOA air and water contamination. A court approved settlement was reached between the plaintiffs and the other co-defendants regarding the Baker Class Action case. In September 2022, the class certification of the Baker Class Action was granted, with the court certifying three separate classes consisting of a private well property damage class, a medical monitoring class and a nuisance class. EID will challenge the certification, and continue to defend itself on the merits of the case, while seeking an out of court resolution. EID is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. Additionally, EID along with Chemours and others, have been named defendants in complaints filed by 11 water districts in Nassau County, New York alleging that the drinking water they provide to customers is contaminated with PFAS and seeking reimbursement for clean-up costs. The water district complaints also include allegations of fraudulent transfer. New Jersey . As of September 30, 2022, two lawsuits were pending, one brought by a local water utility and the second a putative class action, against EID alleging that PFOA from EID’s former Chambers Works facility contaminated drinking water sources. The putative class action was voluntarily dismissed without prejudice by the plaintiff. In late March of 2019, the New Jersey State Attorney General filed four lawsuits against EID, Chemours, and others alleging that operations at and discharges from former EID sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. The Ridgewood Water District in New Jersey filed suit in the first quarter 2019 against EID, Chemours, and others alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants, including PFOA, in water supplies. DuPont and Corteva were subsequently added as defendants to these lawsuits. These lawsuits include claims under the New Jersey Industrial Site Recovery Act ("ISRA") and for fraudulent conveyance. Alabama / Georgia / Others . EID is one of more than 30 defendants in lawsuits by Alabama and Georgia water utilities alleging contamination from PFCs, including PFOA, used by co-defendant carpet manufacturers to make their products more stain and grease resistant. In addition, the states of Alaska, Florida, Michigan, Mississippi, New Hampshire, North Carolina, South Dakota, Vermont and Wisconsin filed lawsuits against EID, Chemours, and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. Motions to dismiss the Michigan, Vermont and New Hampshire cases have been denied. Ohio . EID is a defendant in three lawsuits, including an action by the State of Ohio based on alleged damage to natural resources, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS in water supplies. The trial with respect to the natural resources lawsuit is scheduled for February 2024. The third lawsuit, a putative nationwide class action brought on behalf of anyone who has detectable levels of PFAS in their blood serum seeks declaratory and injunctive relief, including the establishment of a “PFAS Science Panel.” In March 2022, the trial court certified a class covering anyone subject to Ohio laws having minimal levels of PFOA plus at least one other PFAS in their blood. The trial court requested further briefing on whether the class should be extended to include other states that recognize analogous claims for relief. Because EID and the other defendants were granted permission by the court to appeal the class certification decision, further briefing on the extension of the class for the trial court has been paused subject to the outcome of the appeal. Netherlands . In April 2021, four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours. The municipalities seek to recover costs incurred due to the alleged emissions, including damages for investigation costs, construction project delays, depreciation of land, soil remediation, liabilities to contractors, and attorneys’ fees. In September 2022, the court ordered a hearing on the merits to occur by May 2023. Delaware . On July 13, 2021, Chemours, DuPont, EID and Corteva entered into a settlement agreement with the State of Delaware reflecting the companies’ and the State’s agreement to settle and fully resolve claims alleged against the companies regarding their historical Delaware operations, manufacturing, use and disposal of all chemical compounds, including PFAS. Under the settlement, the companies will collectively pay $50 million to fund environmental projects, including sampling and community environmental justice and equity grants, which shall be utilized to fund the Natural Resources and Sustainability Trust (the “NRS Trust”). If the companies, individually or jointly, within 8 years of the settlement, enter into a proportionally similar agreement to settle or resolve claims of another state for PFAS-related natural resource damages, for an amount greater than $50 million, the companies shall make a supplemental payment directly to the NRS Trust (“Supplemental Payment”) in an amount equal to such other states’ recovery in excess of $50 million. Supplemental Payment(s), if any, will not exceed $25 million in the aggregate. All amounts paid by the companies under the settlement are subject to the MOU and the Corteva Separation Agreement with Chemours bearing responsibility for 50%, or $25 million, of the $50 million payment due to the NRS Trust and DuPont and Corteva each bearing $12.5 million of the remaining amount, which Corteva paid in January 2022. During the three months ended September 30, 2021, the company recorded a charge of $11 million to (loss) income from discontinued operations after income taxes in the interim Consolidated Statement of Operations, related to the settlement. Under the settlement, if the state sues other parties and those parties seek contribution from the companies, the companies will have protection from contribution up to the amounts previously paid under the settlement agreement. The companies will also receive a credit up to the amount of the payment if the state seeks natural resource damage claims against the companies outside the scope of the settlement’s release of claims. Aqueous Firefighting Foams . Approximately 3,100 cases have been filed against 3M and other defendants, including EID and Chemours, and some including Corteva and DuPont, alleging PFOS or PFOA contamination of soil and groundwater from the use of aqueous firefighting foams. Most of those cases claim some form of property damage and seek to recover the costs of responding to this contamination and damages for the loss of use and enjoyment of property and diminution in value. Most of these cases have been transferred to a multi-district litigation proceeding in federal district court in South Carolina. Approximately 2,800 of these cases were filed on behalf of firefighters who allege personal injuries (primarily kidney and testicular cancer) as a result of aqueous firefighting foams. Approximately 230 of these cases were filed by water utility or municipal water districts. Most of these recent cases assert claims that the EID and Chemours separation constituted a fraudulent conveyance. The Stuart, Florida water district "bellwether" trial is scheduled for June 2023. The court has encouraged all parties to discuss resolution of the water utility and water district category of cases. Consistent with the Court's instruction and under the mutual obligations of the MOU, Corteva, EID, DuPont and Chemours have engaged with the plaintiff's counsel on these cases. EID did not make firefighting foams, PFOS, or PFOS products. While EID made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EID’s products were not formulated with PFOA, nor was PFOA an ingredient of these products. EID has never made or sold PFOA as a commercial product. In June 2022, the U.S. Environmental Protection Agency ("EPA") published interim health advisories for PFOA and PFOS lowering previous health advisory guidance for drinking water. Health advisories provide drinking water system operators, and state, tribal, and local officials who have the primary responsibility for overseeing these systems, with information on the health risks related to chemicals, so appropriate actions may be taken to protect their constituents. The advisories are not regulations or legally enforceable Federal standards, except as it relates to the Consent Order between Chemours and the North Carolina Department of Environmental Quality (“NC DEQ”), and were published without engagement in the public comment process required for developing regulations. Health advisories are subject to revision as additional information becomes available and the company continues to monitor these developments. The American Chemistry Council (“ACC”) filed a challenge to the health advisories asserting that EPA failed to follow its own rules in issuing the health advisory guidance, did so against the objections of its own PFAS advisory panel, and bypassed the Congress. The EPA moved to dismiss this challenge arguing that the challenge is premature due to the lack of standing (no showing of actual harm) by ACC members and because of the interim nature of the advisories. Fayetteville Works Facility, North Carolina Prior to the separation of Chemours, EID introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operated by Chemours, which continues to manufacture and use GenX. In June 2022, the EPA issued a final health advisory for drinking water related to GenX. In July 2022, Chemours filed a petition in federal court for review of the EPA's GenX compounds health advisory. At September 30, 2022, several actions are pending in federal court against Chemours and EID relating to PFC discharges from the Fayetteville Works facility. One of these is a consolidated putative class action that asserts claims for medical monitoring and property damage on behalf of putative classes of property owners and residents in areas near or who draw drinking water from the Cape Fear River. Another action is a consolidated action brought by various North Carolina water authorities, including the Cape Fear Public Utility Authority and Brunswick County, that seek actual and punitive damages as well as injunctive relief. In another action over approximately 100 property owners near the Fayetteville Works facility filed a complaint against Chemours and EID in May 2020. The plaintiffs seek compensatory and punitive damages for their claims of private nuisance, trespass, and negligence allegedly caused by release of PFAS. In addition to the federal court actions, there is an action on behalf of about 100 plaintiffs who own wells and property near the Fayetteville Works facility. The plaintiffs seek damages for nuisance allegedly caused by releases of certain PFCs from the site. Generally, site-related expenses related to GenX claims are subject to the cost sharing arrangements as defined in the MOU. Environmental Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on cu

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	STOCKHOLDERS' EQUITY Share Buyback Plan On September 13, 2022, Corteva, Inc. announced that its Board of Directors authorized a $2 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2022 Share Buyback Plan"). On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). In connection with the 2021 Share Buyback Plan, the company repurchased and retired 3,414,000 shares and 14,284,000 shares in the open market for a total cost of $200 million and $800 million during the three and nine months ended September 30, 2022, respectively. On June 26, 2019, Corteva, Inc. announced that its Board of Directors authorized a $1 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2019 Share Buyback Plan"). In connection with the 2019 Share Buyback Plan, the company repurchased and retired 3,408,000 shares and 15,378,000 shares in the open market for a total cost of $150 million and $700 million during the three and nine months ended September 30, 2021, respectively. Repurchases under the 2019 Share Buyback Plan were completed during the third quarter of 2021. The timing, price and volume of purchases in connection with the 2022 and 2021 Share Buyback Plans will be based on market conditions, relevant securities laws and other factors. Shares repurchased pursuant to Corteva's share buyback plans are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to APIC. When Corteva has retained earnings, the excess is charged entirely to retained earnings. Noncontrolling Interest Corteva, Inc. owns 100 percent of the outstanding common shares of EID. However, EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Consolidated Balance Sheets. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution. Below is a summary of the EID Preferred Stock at September 30, 2022, December 31, 2021, and September 30, 2021, which is classified as noncontrolling interests in Corteva's interim Consolidated Balance Sheets. Shares in thousands Number of Shares Authorized 23,000 $4.50 Series, callable at $120 1,673 $3.50 Series, callable at $102 700 Other Comprehensive Income (Loss) The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below: (In millions) Cumulative Translation Adjustment 1 Derivative Instruments Pension Benefit Plans Other Benefit Plans Unrealized Gain (Loss) on Investments Total 2021 Balance January 1, 2021 $ (1,970) $ (67) $ (1,433) $ 590 $ (10) $ (2,890) Other comprehensive income (loss) before reclassifications (424) 115 (6) 1 3 (311) Amounts reclassified from accumulated other comprehensive income (loss) — (8) 32 (475) 7 (444) Net other comprehensive income (loss) (424) 107 26 (474) 10 (755) Balance September 30, 2021 $ (2,394) $ 40 $ (1,407) $ 116 $ — $ (3,645) 2022 Balance January 1, 2022 $ (2,543) $ 72 $ (396) $ (31) $ — $ (2,898) Other comprehensive income (loss) before reclassifications (868) 92 107 3 — (666) Amounts reclassified from accumulated other comprehensive income (loss) — (50) 21 1 — (28) Net other comprehensive income (loss) (868) 42 128 4 — (694) Balance September 30, 2022 $ (3,411) $ 114 $ (268) $ (27) $ — $ (3,592) 1. The cumulative translation adjustment gain for the nine months ended September 30, 2022 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF"), Indian Rupee ("INR") and South African Rand ("ZAR"). The cumulative translation adjustment loss for the nine months ended September 30, 2021 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF") and Brazilian Real ("BRL"). The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows: (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Derivative instruments $ (13) $ (12) $ (13) $ (37) Pension benefit plans - net (30) (3) (35) (8) Other benefit plans - net — 51 3 148 (Provision for) benefit from income taxes related to other comprehensive income (loss) items $ (43) $ 36 $ (45) $ 103 A summary of the reclassifications out of accumulated other comprehensive income (loss) is provided as follows: (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Derivative Instruments 1 : $ 33 $ 6 $ (68) $ (9) Tax (benefit) expense 2 (5) (1) 18 1 After-tax $ 28 $ 5 $ (50) $ (8) Amortization of pension benefit plans: Prior service (benefit) cost 3,4 $ — $ — $ (2) $ (1) Actuarial (gains) losses 3,4 — 14 2 41 Settlement (gain) loss 3,4 25 — 27 1 Total before tax $ 25 $ 14 $ 27 $ 41 Tax (benefit) expense 2 (6) (3) (6) (9) After-tax $ 19 $ 11 $ 21 $ 32 Amortization of other benefit plans: Prior service (benefit) cost 3,4 $ — $ (231) $ (1) $ (692) Actuarial (gains) loss 3,4 1 23 2 70 Curtailment (gain) loss — — — (1) Total before tax $ 1 $ (208) $ 1 $ (623) Tax (benefit) expense 2 — 51 — 148 After-tax $ 1 $ (157) $ 1 $ (475) Unrealized Loss on Investments 4 $ — $ — $ — $ 7 Tax (benefit) expense 2 — — — — After-tax $ — $ — $ — $ 7 Total reclassifications for the period, after-tax $ 48 $ (141) $ (28) $ (444) 1. Reflected in cost of goods sold in the interim Consolidated Statements of Operations. 2. Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations. 3. These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 14 - Pension Plans and Other Post Employment Benefits, for additional information.

Pension Plans and Other Post Em

Pension Plans and Other Post Employment Benefit Plans	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Pension and other Post Employment Benefits	PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS The following sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits: Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Defined Benefit Pension Plans: Service cost $ 5 $ 7 $ 14 $ 19 Interest cost 126 91 343 273 Expected return on plan assets (180) (228) (560) (686) Amortization of unrecognized (gain) loss — 14 2 41 Amortization of prior service (benefit) cost — — (2) (1) Settlement loss 25 — 27 1 Net periodic benefit (credit) cost $ (24) $ (116) $ (176) $ (353) Other Post Employment Benefits: Service cost $ — $ 1 $ 1 $ 1 Interest cost 6 5 19 16 Amortization of unrecognized (gain) loss 1 23 2 70 Amortization of prior service (benefit) cost — (231) (1) (692) Curtailment (gain) loss — — — (1) Net periodic benefit (credit) cost $ 7 $ (202) $ 21 $ (606)

Financial Instruments

Financial Instruments	9 Months Ended
	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments Disclosure [Text Block]	FINANCIAL INSTRUMENTS At September 30, 2022, December 31, 2021 and September 30, 2021, the company had $921 million, $3,400 million and $2,108 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents in the interim Consolidated Balance Sheets, as these securities had maturities of three months or less at the time of purchase; $119 million, $86 million and $103 million at September 30, 2022, December 31, 2021 and September 30, 2021, respectively, of held-to-maturity securities (primarily time deposits and foreign government bonds) classified as marketable securities in the interim Consolidated Balance Sheets, as these securities had maturities of more than three months to less than one year at the time of purchase; and $24 million at September 30, 2022 of held-to-maturity securities (primarily foreign government bonds) classified as marketable securities and included in other assets in the interim Consolidated Balance Sheets, as these securities had maturities more than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. The company’s held-to-maturity securities relating to investments in foreign government bonds at September 30, 2022 and available-for-sale securities sold during the nine months ended September 30, 2021 are discussed further in the “Debt Securities” section. Derivative Instruments Objectives and Strategies for Holding Derivative Instruments In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk. Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments. The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management. The notional amounts of the company's derivative instruments were as follows: Notional Amounts (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Derivatives designated as hedging instruments: Foreign currency contracts $ 948 $ 1,252 $ 1,227 Commodity contracts $ 1,424 $ 845 $ 262 Derivatives not designated as hedging instruments: Foreign currency contracts $ 1,371 $ 103 $ 1,164 Commodity contracts $ 3 $ 4 $ 7 Foreign Currency Risk The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes and to mitigate the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows. The company uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries. Commodity Price Risk Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures. Derivatives Designated as Cash Flow Hedges Commodity Contracts The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, forwards, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures. While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring. The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive income (loss): Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Beginning balance $ 81 $ 73 $ 47 $ (16) Additions and revaluations of derivatives designated as cash flow hedges (25) (10) 91 93 Clearance of hedge results to earnings (4) (4) (86) (18) Ending balance $ 52 $ 59 $ 52 $ 59 At September 30, 2022, an after-tax net gain of $50 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months. Foreign Currency Contracts The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries. While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring. The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive income (loss): Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Beginning balance $ (31) $ (21) $ 32 $ (17) Additions and revaluations of derivatives designated as cash flow hedges 11 8 (56) 3 Clearance of hedge results to earnings 32 9 36 10 Ending balance $ 12 $ (4) $ 12 $ (4) At September 30, 2022, an after-tax net gain of $8 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months. Derivatives Designated as Net Investment Hedges Foreign Currency Contracts The company has designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts is to mitigate FX exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges will expire and be settled in 2023, unless terminated early at the discretion of the company. The company elected to apply the spot method in testing for effectiveness of the hedging relationship. Derivatives not Designated in Hedging Relationships Foreign Currency Contracts The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period. Commodity Contracts The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements, with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures. Fair Value of Derivative Instruments Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows: September 30, 2022 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 101 $ — $ 101 Commodity contracts Other current assets 3 — 3 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 112 (58) 54 Total asset derivatives $ 216 $ (58) $ 158 Liability derivatives: Derivatives designated as hedging instruments: Commodity contracts Accrued and other current liabilities 2 — 2 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 63 (58) 5 Total liability derivatives $ 65 $ (58) $ 7 December 31, 2021 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 37 $ — $ 37 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 31 (20) 11 Commodity contracts Other current assets 3 — 3 Total asset derivatives $ 71 $ (20) $ 51 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 1 $ — $ 1 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 23 (20) 3 Commodity contracts Accrued and other current liabilities 2 — 2 Total liability derivatives $ 26 $ (20) $ 6 September 30, 2021 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 20 $ — $ 20 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 37 (23) 14 Total asset derivatives $ 57 $ (23) $ 34 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 9 $ — $ 9 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 31 (23) 8 Total liability derivatives $ 40 $ (23) $ 17 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Effect of Derivative Instruments Amount of Gain (Loss) Recognized in OCI - Pre-Tax 1 Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Derivatives designated as hedging instruments: Net investment hedges: Foreign currency contracts $ 47 $ 10 $ 74 $ 24 Cash flow hedges: Foreign currency contracts 13 18 (68) 12 Commodity contracts (30) (11) 117 117 Total derivatives designated as hedging instruments $ 30 $ 17 $ 123 $ 153 1. OCI is defined as other comprehensive income (loss). Amount of Gain (Loss) Recognized in Income - Pre-Tax 1 Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Derivatives designated as hedging instruments: Cash flow hedges: Foreign currency contracts 2 $ (39) $ (10) $ (44) $ (11) Commodity contracts 2 6 4 112 20 Total derivatives designated as hedging instruments $ (33) $ (6) $ 68 $ 9 Derivatives not designated as hedging instruments: Foreign currency contracts 3 $ 67 $ 34 $ 24 $ — Foreign currency contracts 2 4 12 (1) (16) Commodity contracts 2 5 (1) (21) (18) Total derivatives not designated as hedging instruments 76 45 2 (34) Total derivatives $ 43 $ 39 $ 70 $ (25) 1. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. 2. Recorded in cost of goods sold in the interim Consolidated Statements of Operations. 3. Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 5 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information. Debt Securities The company’s debt securities at September 30, 2022 include foreign government bonds classified as held-to-maturity securities. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value, and are held by certain foreign subsidiaries in which the USD is the functional currency. During the three and nine months ended September 30, 2021, the company sold its U.S. treasuries classified as available-for-sale securities.The estimated fair value of the available-for-sale securities that were sold during the nine months ended September 30, 2021 was determined using Level 1 inputs within the fair value hierarchy. Level 1 measurements were based on quoted market prices in active markets for identical assets and liabilities. The available-for-sale securities that were sold during the three and nine months ended September 30, 2021 were held by certain foreign subsidiaries in which the USD is not the functional currency. The fluctuations in foreign exchange were initially recorded in accumulated other comprehensive income (loss) within the interim Consolidated Statements of Equity and subsequently reclassified to earnings when sold. The gains and losses on these securities offset a portion of the foreign exchange fluctuations in earnings for the company. The following table provides the investing results from available-for-sale securities for the nine months ended September 30, 2021: Investing Results Nine months Ended September 30, (In millions) 2021 Proceeds from sales of available-for-sale securities $ 226 Gross realized losses $ (7) The following table summarizes the contractual maturities of the company's investments in debt securities at September 30, 2022: Contractual Maturities of Debt Securities 1 (In millions) Amortization Cost Fair Value Within one year $ 86 $ 86 One to Five years $ 24 $ 24 1. The company's debt securities at September 30, 2022 consists of foreign government bonds, which are classified as held-to-maturity.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	FAIR VALUE MEASUREMENTS The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis: September 30, 2022 Significant Other Observable Inputs (In millions) Level 1 Level 2 Assets at fair value: Marketable securities $ — $ 119 Derivatives relating to: 1 Foreign currency — 213 Commodity contracts — 3 Total assets at fair value $ — $ 335 Liabilities at fair value: Derivatives relating to: 1 Foreign currency — 63 Commodity contracts — 2 Total liabilities at fair value $ — $ 65 December 31, 2021 Significant Other Observable Inputs (In millions) Level 1 Level 2 Assets at fair value: Marketable securities $ — $ 86 Derivatives relating to: 1 Foreign currency — 68 Equity securities 2 48 — Total assets at fair value $ 48 $ 154 Liabilities at fair value: Derivatives relating to: 1 Foreign currency — 24 Total liabilities at fair value $ — $ 24 September 30, 2021 Significant Other Observable Inputs (In millions) Level 1 Level 2 Assets at fair value: Marketable securities $ — $ 103 Derivatives relating to: 1 Foreign currency — 57 Equity Securities 2 75 — Total assets at fair value $ 75 $ 160 Liabilities at fair value: Derivatives relating to: 1 Foreign currency — 40 Total liabilities at fair value $ — $ 40 1. See Note 15 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets. 2. The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.

Segment Reporting (Notes)

Segment Reporting (Notes)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) benefits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. As of and for the Three Months Ended September 30, (In millions) Seed Crop Protection Total 2022 Net sales $ 862 $ 1,915 $ 2,777 Segment operating EBITDA $ (224) $ 352 $ 128 Segment assets 1 $ 22,665 $ 13,474 $ 36,139 2021 Net sales $ 738 $ 1,633 $ 2,371 Segment operating EBITDA $ (217) $ 206 $ (11) Segment assets 1 $ 23,701 $ 12,539 $ 36,240 1. Segment assets at December 31, 2021 were $23,270 million and $12,428 million for Seed and Crop Protection, respectively. For the Nine Months Ended September 30, (In millions) Seed Crop Protection Total 2022 Net Sales $ 7,333 $ 6,297 $ 13,630 Segment operating EBITDA $ 1,585 $ 1,352 $ 2,937 2021 Net sales $ 7,010 $ 5,166 $ 12,176 Segment operating EBITDA $ 1,523 $ 897 $ 2,420 Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (322) $ 36 $ 1,257 $ 1,667 Provision for (benefit from) income taxes on continuing operations (74) (28) 372 434 Income (loss) from continuing operations before income taxes (396) 8 1,629 2,101 Depreciation and amortization 310 309 919 926 Interest income (36) (19) (75) (58) Interest expense 18 8 43 22 Exchange (gains) losses 13 (2) 96 47 Non-operating (benefits) costs (9) (315) (134) (941) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges (6) (19) (3) 3 Significant items (benefit) charge 202 (21) 379 214 Corporate expenses 32 40 83 106 Segment operating EBITDA $ 128 $ (11) $ 2,937 $ 2,420 Segment assets to total assets (in millions) September 30, 2022 December 31, 2021 September 30, 2021 Total segment assets $ 36,139 $ 35,698 $ 36,240 Corporate assets 4,512 6,646 4,882 Total assets $ 40,651 $ 42,344 $ 41,122 Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA The three and nine months ended September 30, 2022, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA: (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2022 Restructuring and asset related charges - net 1 $ (66) $ (20) $ (66) $ (152) Estimated settlement expense 2 — (40) — (40) Inventory write-offs 3 (32) — — (32) Gain on sale of business 3 — 15 — 15 Settlement cost associated with Russia Exit 3 (2) — — (2) Employee Retention Credit 6 3 — 9 Total $ (94) $ (42) $ (66) $ (202) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2021 Restructuring and asset related charges - net 1 $ (9) $ (8) $ (9) $ (26) Equity securities mark-to-market gain 47 — — 47 Total $ 38 $ (8) $ (9) $ 21 (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2022 Restructuring and asset related charges - net 1 $ (197) $ (20) $ (83) $ (300) Estimated settlement expense 2 — (57) — (57) Inventory write-offs 3 (33) — — (33) Gain on sale of business 3 — 15 — 15 Loss on exit of non-strategic asset 3 (5) — — (5) Settlement costs associated with Russia Exit 3 (8) — — (8) Employee Retention Credit 6 3 — 9 Total $ (237) $ (59) $ (83) $ (379) (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2021 Restructuring and asset related charges - net 1 $ (145) $ (51) $ (65) $ (261) Equity securities mark-to-market gain 47 — — 47 Total $ (98) $ (51) $ (65) $ (214) 1. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information. 2. Consists of estimated Lorsban® related reserves

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS In September 2022, Corteva announced that it has signed a definitive agreement to acquire Quorum Vital Investment, S.L. and its affiliates (“Symborg”), a leader in microbiological technologies. The transaction is subject to customary closing conditions and is expected to be completed in 2022. The company will apply the acquisition method of accounting and expects to complete the preliminary purchase price allocation for the business combination during the fourth quarter of 2022.

EID - Basis of Presentation (No

EID - Basis of Presentation (Notes)	9 Months Ended
	Sep. 30, 2022
EID [Member]
Entity Information [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	BASIS OF PRESENTATION Corteva, Inc. owns 100% of the outstanding common stock of EID. EID is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EID are outlined below: • Preferred Stock - EID has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EID Preferred Stock - $4.50 Series and EID Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EID and was unaffected by the Corteva Distribution. • Related Party Loan - EID engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EID's consolidated financial statements at the standalone level (including the associated interest). • Capital Structure - At September 30, 2022, Corteva, Inc.'s capital structure consists of 716,225,000 issued shares of common stock, par value $0.01 per share. The accompanying footnotes relate to EID only, and not to Corteva, Inc., and are presented to show differences between EID and Corteva, Inc. For the footnotes listed below, refer to the following Corteva, Inc. footnotes: • Note 1 - Summary of Significant Accounting Policies - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements • Note 2 - Recent Accounting Guidance - refer to page 10 of the Corteva, Inc. interim Consolidated Financial Statements • Note 3 - Revenue - refer to page 11 of the Corteva, Inc. interim Consolidated Financial Statements • Note 4 - Restructuring and Asset Related Charges - Net - refer to page 13 of the Corteva, Inc. interim Consolidated Financial Statements • Note 5 - Supplementary Information - refer to page 15 of the Corteva, Inc. interim Consolidated Financial Statements • Note 6 - Income Taxes - refer to page 17 of the Corteva, Inc. interim Consolidated Financial Statements • Note 7 - Earnings Per Share of Common Stock - Not applicable for EID • Note 8 - Accounts and Notes Receivable - Net - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements • Note 9 - Inventories - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements • Note 10 - Other Intangible Assets - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements • Note 11 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EID has a related party loan payable to Corteva, Inc.; refer to EID Note 2 - Related Party Transactions, below • Note 12 - Commitments and Contingent Liabilities - refer to page 23 of the Corteva, Inc. interim Consolidated Financial Statements • Note 13 - Stockholders' Equity - refer to page 30 of the Corteva, Inc. interim Consolidated Financial Statements • Note 14 - Pension Plans and Other Post Employment Benefits - refer to page 33 of the Corteva, Inc. interim Consolidated Financial Statements • Note 15 - Financial Instruments - refer to page 33 of the Corteva, Inc. interim Consolidated Financial Statements • Note 16 - Fair Value Measurements - refer to page 39 of the Corteva, Inc. interim Consolidated Financial Statements • Note 17 - Segment Information - Differences exist between Corteva, Inc. and EID; refer to EID Note 3 - Segment Information, below • Note 18 - Subsequent Events - refer to page 43 of the Corteva, Inc. interim Consolidated Financial Statements

EID - Related Party Transaction

EID - Related Party Transactions (Notes)	9 Months Ended
	Sep. 30, 2022
EID [Member]
Related Party Transaction [Line Items]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Transactions with Corteva In the second quarter of 2019, EID entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of September 30, 2022, December 31, 2021, and September 30, 2021, the outstanding related party loan balance was $1,066 million, $2,162 million, and $2,443 million, respectively (which approximates fair value), with interest rates of 4.12%, 1.67%, and 1.52%, respectively, and is reflected as long-term debt - related party in EID's interim Consolidated Balance Sheets. Additionally, EID has incurred tax deductible interest expense of $14 million and $33 million for the three and nine months ended September 30, 2022, respectively, and $11 million and $39 million for the three and nine months ended September 30, 2021, respectively, associated with the related party loan from Corteva, Inc. As of September 30, 2022, December 31, 2021, and September 30, 2021, EID had payables to Corteva, Inc., of $24 million, $27 million and $61 million included in accrued and other current liabilities, respectively, and $122 million, $117 million, and $90 million, included in other noncurrent obligations, respectively, in the interim Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 24 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).

EID Segment FN (Notes)

EID Segment FN (Notes)	9 Months Ended
	Sep. 30, 2022
Segment Reporting Information [Line Items]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) benefits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy EID businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. As of and for the Three Months Ended September 30, (In millions) Seed Crop Protection Total 2022 Net sales $ 862 $ 1,915 $ 2,777 Segment operating EBITDA $ (224) $ 352 $ 128 Segment assets 1 $ 22,665 $ 13,474 $ 36,139 2021 Net sales $ 738 $ 1,633 $ 2,371 Segment operating EBITDA $ (217) $ 206 $ (11) Segment assets 1 $ 23,701 $ 12,539 $ 36,240 1. Segment assets at December 31, 2021 were $23,270 million and $12,428 million for Seed and Crop Protection, respectively. For the Nine Months Ended September 30, (In millions) Seed Crop Protection Total 2022 Net Sales $ 7,333 $ 6,297 $ 13,630 Segment operating EBITDA $ 1,585 $ 1,352 $ 2,937 2021 Net sales $ 7,010 $ 5,166 $ 12,176 Segment operating EBITDA $ 1,523 $ 897 $ 2,420 Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (322) $ 36 $ 1,257 $ 1,667 Provision for (benefit from) income taxes on continuing operations (74) (28) 372 434 Income (loss) from continuing operations before income taxes (396) 8 1,629 2,101 Depreciation and amortization 310 309 919 926 Interest income (36) (19) (75) (58) Interest expense 18 8 43 22 Exchange (gains) losses 13 (2) 96 47 Non-operating (benefits) costs (9) (315) (134) (941) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges (6) (19) (3) 3 Significant items (benefit) charge 202 (21) 379 214 Corporate expenses 32 40 83 106 Segment operating EBITDA $ 128 $ (11) $ 2,937 $ 2,420 Segment assets to total assets (in millions) September 30, 2022 December 31, 2021 September 30, 2021 Total segment assets $ 36,139 $ 35,698 $ 36,240 Corporate assets 4,512 6,646 4,882 Total assets $ 40,651 $ 42,344 $ 41,122 Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA The three and nine months ended September 30, 2022, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA: (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2022 Restructuring and asset related charges - net 1 $ (66) $ (20) $ (66) $ (152) Estimated settlement expense 2 — (40) — (40) Inventory write-offs 3 (32) — — (32) Gain on sale of business 3 — 15 — 15 Settlement cost associated with Russia Exit 3 (2) — — (2) Employee Retention Credit 6 3 — 9 Total $ (94) $ (42) $ (66) $ (202) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2021 Restructuring and asset related charges - net 1 $ (9) $ (8) $ (9) $ (26) Equity securities mark-to-market gain 47 — — 47 Total $ 38 $ (8) $ (9) $ 21 (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2022 Restructuring and asset related charges - net 1 $ (197) $ (20) $ (83) $ (300) Estimated settlement expense 2 — (57) — (57) Inventory write-offs 3 (33) — — (33) Gain on sale of business 3 — 15 — 15 Loss on exit of non-strategic asset 3 (5) — — (5) Settlement costs associated with Russia Exit 3 (8) — — (8) Employee Retention Credit 6 3 — 9 Total $ (237) $ (59) $ (83) $ (379) (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2021 Restructuring and asset related charges - net 1 $ (145) $ (51) $ (65) $ (261) Equity securities mark-to-market gain 47 — — 47 Total $ (98) $ (51) $ (65) $ (214) 1. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information. 2. Consists of estimated Lorsban® related reserves
EID [Member]
Segment Reporting Information [Line Items]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION There are no differences in reporting structure or segments between Corteva, Inc. and EID. In addition, there are no differences between Corteva, Inc. and EID segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 40 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EID. Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (333) $ 27 $ 1,232 $ 1,637 Provision for (benefit from) income taxes on continuing operations (77) (30) 364 425 Income (loss) from continuing operations before income taxes (410) (3) 1,596 2,062 Depreciation and amortization 310 309 919 926 Interest income (36) (19) (75) (58) Interest expense 32 19 76 61 Exchange (gains) losses 13 (2) 96 47 Non-operating (benefits) costs (9) (315) (134) (941) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges (6) (19) (3) 3 Significant items (benefit) charge 202 (21) 379 214 Corporate expenses 32 40 83 106 Segment operating EBITDA $ 128 $ (11) $ 2,937 $ 2,420

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2021, collectively referred to as the “2021 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual Sales and EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 5 – Supplementary Information, to the interim Consolidated Financial Statements, and Note 9 – Supplemental Information, to the company's 2021 Annual Report). As of September 30, 2022, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $20 million. We will continue to assess the implications to our operations and financial reporting. In April 2022, the company implemented a global business unit organization model (“BU Reorganization”). While the new organization model had no impact on our determination of operating segments, it did result in the company’s digital reporting unit being merged into the seed and crop protection reporting units with the goodwill relating to the former digital reporting unit being reassigned to the seed and crop protection reporting units using a relative fair value allocation approach. The impact of the BU Reorganization did not have a material impact to the company’s historical reportable segments’ financial measures. An interim goodwill impairment assessment immediately prior to the BU Reorganization and for the seed and crop protection reporting units immediately after the BU Reorganization resulted in no goodwill impairment charges. Qualitative impairment assessments were performed for the seed and crop protection reporting units. The qualitative assessments included an evaluation of relevant factors including GDP growth rates, long-term commodity prices, equity and credit market activity, discount rates, changes in the industry and market structure, competitive environments, cost factors such as raw material prices, and overall financial performance. Based on the qualitative assessments performed, it was more likely than not that the fair value of each reporting unit exceeded the carrying value and therefore a quantitative test was not performed . A quantitative impairment assessment was performed for the former digital reporting unit using a combination of the discounted cash flow model (a form of the income approach) and the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The company's significant assumptions in this analysis included future cash flow projections, weighted average cost of capital, the terminal growth rate and the tax rate. The company’s estimate of future cash flows is based on current regulatory and economic climates, recent operating results, and assumed business strategy from a market participant perspective and includes an estimate of a long-term future growth rate based on such strategy. Actual results may differ from those assumed in the company’s forecast. The company derives its discount rate using a capital asset pricing model and analyzes published rates for industries relevant to its reporting unit to estimate the cost of equity financing. The company uses a discount rate that is commensurate with the risks and uncertainty inherent in the reporting unit and in its internally developed forecast. Under the market approach, the company uses historically completed transactions for comparable companies.

Recent Accounting Guidance Rece

Recent Accounting Guidance Recent Accounting Guidance (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Recent Accounting Guidance	Recently Adopted Accounting Guidance In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance, which requires business entities to disclose transactions with a governmental entity for which a grant or contribution accounting model is used in recognizing and measuring such transactions. This standard is effective for fiscal years beginning after December 15, 2021, and early adoption is permitted. The company adopted this guidance on January 1, 2022 and it did not have a material impact on the company’s disclosures. Accounting Guidance Issued But Not Adopted as of September 30, 2022 In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. This ASU includes amendments that require a buyer in supplier finance programs to disclose key terms of the programs and related obligations, including a rollforward of such obligations. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the rollforward requirements, which is effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. Retrospective application to all periods in which a balance sheet is presented is required, except for the rollforward requirement, which will be applied prospectively. The adoption of this guidance will result in the company being required to include certain disclosures relating to supplier financing programs and related obligations.

Revenue Revenue Recognition (Po

Revenue Revenue Recognition (Policies)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition, Sales of Goods	Products Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years. Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less. The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.
Revenue Recognition, Licenses of Intellectual Property	Licenses of Intellectual PropertyCorteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Contract Balances	Contract Balances September 30, 2022 December 31, 2021 September 30, 2021 (In millions) Accounts and notes receivable - trade 1 $ 4,875 $ 3,561 $ 4,744 Contract assets - current 2 $ 25 $ 24 $ 24 Contract assets - noncurrent 3 $ 62 $ 58 $ 60 Deferred revenue - current $ 860 $ 3,201 $ 692 Deferred revenue - noncurrent 4 $ 108 $ 120 $ 111 1. Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets. 2. Included in other current assets in the interim Consolidated Balance Sheets. 3. Included in other assets in the interim Consolidated Balance Sheets.
Major Product Line [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue	Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Corn $ 469 $ 437 $ 4,621 $ 4,505 Soybean 205 157 1,685 1,494 Other oilseeds 124 94 647 661 Other 64 50 380 350 Seed 862 738 7,333 7,010 Herbicides 1,043 782 3,472 2,737 Insecticides 363 416 1,275 1,261 Fungicides 421 339 1,173 911 Other 88 96 377 257 Crop Protection 1,915 1,633 6,297 5,166 Total $ 2,777 $ 2,371 $ 13,630 $ 12,176
Geography [Domain]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue	Seed Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 North America 1 $ 218 $ 168 $ 4,637 $ 4,482 EMEA 2 157 153 1,442 1,398 Latin America 383 334 912 842 Asia Pacific 104 83 342 288 Total $ 862 $ 738 $ 7,333 $ 7,010 Crop Protection Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 North America 1 $ 521 $ 422 $ 2,185 $ 1,693 EMEA 2 297 237 1,452 1,304 Latin America 898 763 1,852 1,361 Asia Pacific 199 211 808 808 Total $ 1,915 $ 1,633 $ 6,297 $ 5,166 1. Represents U.S. & Canada. 2. Europe, Middle East, and Africa ("EMEA").

Restructuring and Asset Relat_2

Restructuring and Asset Related Charges (Tables)	9 Months Ended
	Sep. 30, 2022
2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	Three Months Ended September 30, Nine Months Ended (In millions) 2022 2022 Seed $ 61 $ 94 Crop Protection 19 20 Corporate expenses 66 88 Total 1 $ 146 $ 202 1. This amount excludes the pre-tax charges impacting Seed recorded to cost of goods sold and other income - net in the company's interim Consolidated Statement of Operations, relating to inventory write-offs of $33 million, and a gain on sale of a business of $15 million, settlement costs associated with the Russia Exit, and charges associated with the exit of a non-strategic asset of $5 million, respectively. The following table is a summary of charges incurred related to 2022 Restructuring Actions for the three and nine months ended September 30, 2022: Three Months Ended September 30, Nine Months Ended (In millions) 2022 2022 Severance and related benefit costs $ 66 $ 88 Asset related charges 66 70 Contract termination charges 1 14 44 Total restructuring and asset related charges - net 2 $ 146 $ 202 1. Contract terminations includes early lease terminations. 2. This amount excludes the pre-tax charges recorded to the cost of goods sold and other income - net in the interim Consolidated Statement of Operations, relating to inventory write-offs of $33 million, and a gain on sale of a business of $15 million, settlement costs associated with the Russia Exit and charges associated with the exit of a non-strategic asset of $5 million, respectively. A reconciliation of the December 31, 2021 to the September 30, 2022 liability balances related to the 2022 Restructuring Actions is summarized below: (in millions) Severance and Related Benefit Costs Asset Related Contract Termination 1 Total Balance at December 31, 2021 $ — $ — $ — $ — Charges to income (loss) from continuing operations 88 70 44 202 Payments (19) — (5) (24) Asset write-offs — (70) — (70) Balance at September 30, 2022 $ 69 $ — $ 39 $ 108 1. The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022.
2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Seed $ 1 $ 4 $ (1) $ 21 Crop Protection (1) 4 (3) 41 Corporate expenses — 9 3 65 Total $ — $ 17 $ (1) $ 127 The following table is a summary of charges incurred related to 2021 Restructuring Actions for the three and nine months ended September 30, 2022 and 2021: Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Severance and related benefit costs $ — $ 9 $ 3 $ 58 Asset related charges — 7 (1) 29 Contract termination charges — 1 (3) 40 Total restructuring and asset related charges - net $ — $ 17 $ (1) $ 127 A reconciliation of the December 31, 2021 to the September 30, 2022 liability balances related to the 2021 Restructuring Actions is summarized below: (In millions) Severance and Related Benefit Costs Asset Related 1 Contract Termination Total Balance at December 31, 2021 $ 52 $ — $ 12 $ 64 Charges to income (loss) from continuing operations 3 (1) (3) (1) Payments (35) — (8) (43) Asset write-offs — 1 — 1 Balance at September 30, 2022 $ 20 $ — $ 1 $ 21

Supplementary Information (Tabl

Supplementary Information (Tables)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other Nonoperating Income (Expense)	Other Income - Net Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Interest income $ 36 $ 19 $ 75 $ 58 Equity in earnings (losses) of affiliates - net (1) (1) 13 4 Net gain (loss) on sales of businesses and other assets 16 1 17 2 Net exchange gains (losses) 1 (13) 2 (96) (47) Non-operating pension and other post employment benefit credit (costs) 2 22 326 170 979 Miscellaneous income (expenses) - net 3 (37) 31 (90) 17 Other income - net $ 23 $ 378 $ 89 $ 1,013 1. Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively. 2. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).
Foreign Currency Exchange Gain (Loss)	(In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Subsidiary Monetary Position Gain (Loss) Pre-tax exchange gain (loss) $ (80) $ (32) $ (120) $ (47) Local tax (expenses) benefits (40) 3 (61) (11) Net after-tax impact from subsidiary exchange gain (loss) $ (120) $ (29) $ (181) $ (58) Hedging Program Gain (Loss) Pre-tax exchange gain (loss) $ 67 $ 34 $ 24 $ — Tax (expenses) benefits (15) (8) (5) — Net after-tax impact from hedging program exchange gain (loss) $ 52 $ 26 $ 19 $ — Total Exchange Gain (Loss) Pre-tax exchange gain (loss) $ (13) $ 2 $ (96) $ (47) Tax (expenses) benefits (55) (5) (66) (11) Net after-tax exchange gain (loss) $ (68) $ (3) $ (162) $ (58)
Restrictions on Cash and Cash Equivalents	(In millions) September 30, 2022 December 31, 2021 September 30, 2021 Cash and cash equivalents $ 2,199 $ 4,459 $ 2,779 Restricted cash equivalents 420 377 361 Total cash, cash equivalents and restricted cash equivalents $ 2,619 $ 4,836 $ 3,140

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (322) $ 36 $ 1,257 $ 1,667 Net income (loss) attributable to continuing operations noncontrolling interests 3 2 9 8 Income (loss) from continuing operations available to Corteva common stockholders (325) 34 1,248 1,659 (Loss) income from discontinued operations available to Corteva common stockholders (6) (4) (46) (59) Net income (loss) available to common stockholders $ (331) $ 30 $ 1,202 $ 1,600
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]	Earnings (Loss) Per Share Calculations - Basic Three Months Ended Nine Months Ended (Dollars per share) 2022 2021 2022 2021 Earnings (loss) per share of common stock from continuing operations $ (0.45) $ 0.05 $ 1.73 $ 2.25 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) (0.06) (0.08) Earnings (loss) per share of common stock $ (0.46) $ 0.04 $ 1.67 $ 2.17
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]	Earnings (Loss) Per Share Calculations - Diluted Three Months Ended Nine Months Ended (Dollars per share) 2022 2021 2022 2021 Earnings (loss) per share of common stock from continuing operations $ (0.45) $ 0.05 $ 1.72 $ 2.23 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) (0.06) (0.08) Earnings (loss) per share of common stock $ (0.46) $ 0.04 $ 1.66 $ 2.15
Share Count Information	Share Count Information Three Months Ended Nine Months Ended (Shares in millions) 2022 2021 2022 2021 Weighted-average common shares - basic 718.7 733.8 722.8 738.1 Plus dilutive effect of equity compensation plans 1 — 5.7 3.6 5.9 Weighted-average common shares - diluted 718.7 739.5 726.4 744.0 Potential shares of common stock excluded from EPS calculations 2 6.1 3.0 2.2 3.1 1. Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. 2. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable_2

Accounts and Notes Receivable (Tables)	9 Months Ended
	Sep. 30, 2022
Accounts and Notes Receivable [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	(In millions) September 30, 2022 December 31, 2021 September 30, 2021 Accounts receivable – trade 1 $ 3,642 $ 3,441 $ 3,336 Notes receivable – trade 1,2 1,233 120 1,408 Other 3 1,398 1,250 1,074 Total accounts and notes receivable - net $ 6,273 $ 4,811 $ 5,818 1. Accounts receivable – trade and notes receivable - trade are net of allowances of $213 million at September 30, 2022, and $210 million at December 31, 2021, and September 30, 2021. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method. 2. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2022, December 31, 2021, and September 30, 2021 there were no significant impairments related to current loan agreements. 3. Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $132 million, $104 million, and $84 million as of September 30, 2022, December 31, 2021, and September 30, 2021, respectively.
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	(In millions) 2021 Balance at December 31, 2020 $ 208 Net benefit for credit losses (7) Write-offs charged against allowance / other 9 Balance at September 30, 2021 $ 210 2022 Balance at December 31, 2021 $ 210 Net provision for credit losses 4 Write-offs charged against allowance / other (1) Balance at September 30, 2022 $ 213

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	(In millions) September 30, 2022 December 31, 2021 September 30, 2021 Finished products $ 2,082 $ 2,497 $ 1,871 Semi-finished products 2,557 2,076 2,028 Raw materials and supplies 776 607 518 Total inventories $ 5,415 $ 5,180 $ 4,417

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Other Intangible Assets	(In millions) September 30, 2022 December 31, 2021 September 30, 2021 Gross Accumulated Net Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization (Definite-lived): Germplasm $ 6,265 $ (762) $ 5,503 $ 6,265 $ (571) $ 5,694 $ 6,265 $ (507) $ 5,758 Customer-related 1,890 (550) 1,340 1,953 (487) 1,466 1,956 (460) 1,496 Developed technology 1,485 (790) 695 1,485 (679) 806 1,485 (641) 844 Trademarks/trade names 2,006 (231) 1,775 2,012 (172) 1,840 2,012 (152) 1,860 Favorable supply contracts 475 (467) 8 475 (396) 79 475 (373) 102 Other 1 395 (265) 130 405 (256) 149 407 (252) 155 Total other intangible assets with finite lives 12,516 (3,065) 9,451 12,595 (2,561) 10,034 12,600 (2,385) 10,215 Intangible assets not subject to amortization (Indefinite-lived): IPR&D 10 — 10 10 — 10 10 — 10 Total other intangible assets 10 — 10 10 — 10 10 — 10 Total $ 12,526 $ (3,065) $ 9,461 $ 12,605 $ (2,561) $ 10,044 $ 12,610 $ (2,385) $ 10,225 1. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Short-Term Borrowings, Long-T_2

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Instrument [Line Items]
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt (in millions) September 30, 2022 December 31, 2021 September 30, 2021 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Other loans: Foreign currency loans, various rates and maturities 176 14.80 % 1 6.82 % 1 6.38 % Medium-term notes, varying maturities through 2041 107 2.87 % 107 — % 108 — % Finance lease obligations 2 3 3 Less: Unamortized debt discount and issuance costs 8 10 10 Less: Long-term debt due within one year — 1 1 Total long-term debt $ 1,277 $ 1,100 $ 1,101
Schedule of Short-term Debt [Table Text Block]	Short-term borrowings and finance lease obligations (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Commercial paper $ 1,369 $ — $ 802 Repurchase facility 200 — 550 Other loans - various currencies 6 15 18 Long-term debt payable within one year — 1 1 Finance lease obligations payable within one year 1 1 1 Total short-term borrowings and finance lease obligations $ 1,576 $ 17 $ 1,372
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt (in millions) September 30, 2022 December 31, 2021 September 30, 2021 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Other loans: Foreign currency loans, various rates and maturities 176 14.80 % 1 6.82 % 1 6.38 % Medium-term notes, varying maturities through 2041 107 2.87 % 107 — % 108 — % Finance lease obligations 2 3 3 Less: Unamortized debt discount and issuance costs 8 10 10 Less: Long-term debt due within one year — 1 1 Total long-term debt $ 1,277 $ 1,100 $ 1,101
Schedule of Line of Credit Facilities	Committed and Available Credit Facilities at September 30, 2022 (in millions) Effective Date Committed Credit Credit Available Maturity Date Interest Revolving Credit Facility May 2022 $ 3,000 $ 3,000 May 2027 Floating Rate Revolving Credit Facility May 2022 2,000 2,000 May 2025 Floating Rate 364-day Revolving Credit Facility May 2022 500 500 May 2023 Floating Rate Total Committed and Available Credit Facilities $ 5,500 $ 5,500

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Environmental Loss Contingencies by Site [Table Text Block]	As of September 30, 2022 (In millions) Indemnification Asset Accrual balance 3 Potential exposure above amount accrued 3 Environmental Remediation Stray Liabilities Chemours related obligations - subject to indemnity 1,2 $ 155 $ 155 $ 266 Other discontinued or divested businesses obligations 1 24 77 185 Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont 2 45 46 62 Environmental remediation liabilities not subject to indemnity — 80 54 Indemnification liabilities related to the MOU 4 21 125 29 Total $ 245 $ 483 $ 596 1. Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page 24, under the header "Corteva Separation Agreement." 2. The company has recorded an indemnification asset related to these accruals, including $36 million related to the Superfund sites. 3. Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balances includes $67 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 28 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the NC DEQ. 4. Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]	Shares in thousands Number of Shares Authorized 23,000 $4.50 Series, callable at $120 1,673 $3.50 Series, callable at $102 700
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	(In millions) Cumulative Translation Adjustment 1 Derivative Instruments Pension Benefit Plans Other Benefit Plans Unrealized Gain (Loss) on Investments Total 2021 Balance January 1, 2021 $ (1,970) $ (67) $ (1,433) $ 590 $ (10) $ (2,890) Other comprehensive income (loss) before reclassifications (424) 115 (6) 1 3 (311) Amounts reclassified from accumulated other comprehensive income (loss) — (8) 32 (475) 7 (444) Net other comprehensive income (loss) (424) 107 26 (474) 10 (755) Balance September 30, 2021 $ (2,394) $ 40 $ (1,407) $ 116 $ — $ (3,645) 2022 Balance January 1, 2022 $ (2,543) $ 72 $ (396) $ (31) $ — $ (2,898) Other comprehensive income (loss) before reclassifications (868) 92 107 3 — (666) Amounts reclassified from accumulated other comprehensive income (loss) — (50) 21 1 — (28) Net other comprehensive income (loss) (868) 42 128 4 — (694) Balance September 30, 2022 $ (3,411) $ 114 $ (268) $ (27) $ — $ (3,592) 1. The cumulative translation adjustment gain for the nine months ended September 30, 2022 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF"), Indian Rupee ("INR") and South African Rand ("ZAR"). The cumulative translation adjustment loss for the nine months ended September 30, 2021 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF") and Brazilian Real ("BRL").
Tax (Expense) Benefit of Other Comprehensive (Loss) Income	(In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Derivative instruments $ (13) $ (12) $ (13) $ (37) Pension benefit plans - net (30) (3) (35) (8) Other benefit plans - net — 51 3 148 (Provision for) benefit from income taxes related to other comprehensive income (loss) items $ (43) $ 36 $ (45) $ 103
Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block]	(In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Derivative Instruments 1 : $ 33 $ 6 $ (68) $ (9) Tax (benefit) expense 2 (5) (1) 18 1 After-tax $ 28 $ 5 $ (50) $ (8) Amortization of pension benefit plans: Prior service (benefit) cost 3,4 $ — $ — $ (2) $ (1) Actuarial (gains) losses 3,4 — 14 2 41 Settlement (gain) loss 3,4 25 — 27 1 Total before tax $ 25 $ 14 $ 27 $ 41 Tax (benefit) expense 2 (6) (3) (6) (9) After-tax $ 19 $ 11 $ 21 $ 32 Amortization of other benefit plans: Prior service (benefit) cost 3,4 $ — $ (231) $ (1) $ (692) Actuarial (gains) loss 3,4 1 23 2 70 Curtailment (gain) loss — — — (1) Total before tax $ 1 $ (208) $ 1 $ (623) Tax (benefit) expense 2 — 51 — 148 After-tax $ 1 $ (157) $ 1 $ (475) Unrealized Loss on Investments 4 $ — $ — $ — $ 7 Tax (benefit) expense 2 — — — — After-tax $ — $ — $ — $ 7 Total reclassifications for the period, after-tax $ 48 $ (141) $ (28) $ (444) 1. Reflected in cost of goods sold in the interim Consolidated Statements of Operations. 2. Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations. 3. These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 14 - Pension Plans and Other Post Employment Benefits, for additional information.

Pension Plans and Other Post _2

Pension Plans and Other Post Employment Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2022
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Defined Benefit Pension Plans: Service cost $ 5 $ 7 $ 14 $ 19 Interest cost 126 91 343 273 Expected return on plan assets (180) (228) (560) (686) Amortization of unrecognized (gain) loss — 14 2 41 Amortization of prior service (benefit) cost — — (2) (1) Settlement loss 25 — 27 1 Net periodic benefit (credit) cost $ (24) $ (116) $ (176) $ (353) Other Post Employment Benefits: Service cost $ — $ 1 $ 1 $ 1 Interest cost 6 5 19 16 Amortization of unrecognized (gain) loss 1 23 2 70 Amortization of prior service (benefit) cost — (231) (1) (692) Curtailment (gain) loss — — — (1) Net periodic benefit (credit) cost $ 7 $ (202) $ 21 $ (606)

Financial Instruments (Tables)

Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Derivative [Line Items]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	Notional Amounts (In millions) September 30, 2022 December 31, 2021 September 30, 2021 Derivatives designated as hedging instruments: Foreign currency contracts $ 948 $ 1,252 $ 1,227 Commodity contracts $ 1,424 $ 845 $ 262 Derivatives not designated as hedging instruments: Foreign currency contracts $ 1,371 $ 103 $ 1,164 Commodity contracts $ 3 $ 4 $ 7
Fair Value of Derivatives Instruments	September 30, 2022 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 101 $ — $ 101 Commodity contracts Other current assets 3 — 3 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 112 (58) 54 Total asset derivatives $ 216 $ (58) $ 158 Liability derivatives: Derivatives designated as hedging instruments: Commodity contracts Accrued and other current liabilities 2 — 2 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 63 (58) 5 Total liability derivatives $ 65 $ (58) $ 7 December 31, 2021 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 37 $ — $ 37 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 31 (20) 11 Commodity contracts Other current assets 3 — 3 Total asset derivatives $ 71 $ (20) $ 51 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 1 $ — $ 1 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 23 (20) 3 Commodity contracts Accrued and other current liabilities 2 — 2 Total liability derivatives $ 26 $ (20) $ 6 September 30, 2021 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 20 $ — $ 20 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 37 (23) 14 Total asset derivatives $ 57 $ (23) $ 34 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 9 $ — $ 9 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 31 (23) 8 Total liability derivatives $ 40 $ (23) $ 17
Effect of Derivatives	Amount of Gain (Loss) Recognized in OCI - Pre-Tax 1 Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Derivatives designated as hedging instruments: Net investment hedges: Foreign currency contracts $ 47 $ 10 $ 74 $ 24 Cash flow hedges: Foreign currency contracts 13 18 (68) 12 Commodity contracts (30) (11) 117 117 Total derivatives designated as hedging instruments $ 30 $ 17 $ 123 $ 153 1. OCI is defined as other comprehensive income (loss). Amount of Gain (Loss) Recognized in Income - Pre-Tax 1 Three Months Ended September 30, Nine Months Ended (In millions) 2022 2021 2022 2021 Derivatives designated as hedging instruments: Cash flow hedges: Foreign currency contracts 2 $ (39) $ (10) $ (44) $ (11) Commodity contracts 2 6 4 112 20 Total derivatives designated as hedging instruments $ (33) $ (6) $ 68 $ 9 Derivatives not designated as hedging instruments: Foreign currency contracts 3 $ 67 $ 34 $ 24 $ — Foreign currency contracts 2 4 12 (1) (16) Commodity contracts 2 5 (1) (21) (18) Total derivatives not designated as hedging instruments 76 45 2 (34) Total derivatives $ 43 $ 39 $ 70 $ (25) 1. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. 2. Recorded in cost of goods sold in the interim Consolidated Statements of Operations.
Schedule of Realized Gains (Losses)	Investing Results Nine months Ended September 30, (In millions) 2021 Proceeds from sales of available-for-sale securities $ 226 Gross realized losses $ (7)
Commodity Contract [Member]
Derivative [Line Items]
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Beginning balance $ 81 $ 73 $ 47 $ (16) Additions and revaluations of derivatives designated as cash flow hedges (25) (10) 91 93 Clearance of hedge results to earnings (4) (4) (86) (18) Ending balance $ 52 $ 59 $ 52 $ 59
Foreign Currency Contract [Member]
Derivative [Line Items]
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	Three Months Ended Nine Months Ended (In millions) 2022 2021 2022 2021 Beginning balance $ (31) $ (21) $ 32 $ (17) Additions and revaluations of derivatives designated as cash flow hedges 11 8 (56) 3 Clearance of hedge results to earnings 32 9 36 10 Ending balance $ 12 $ (4) $ 12 $ (4)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities Measured on Recurring Basis	September 30, 2022 Significant Other Observable Inputs (In millions) Level 1 Level 2 Assets at fair value: Marketable securities $ — $ 119 Derivatives relating to: 1 Foreign currency — 213 Commodity contracts — 3 Total assets at fair value $ — $ 335 Liabilities at fair value: Derivatives relating to: 1 Foreign currency — 63 Commodity contracts — 2 Total liabilities at fair value $ — $ 65 December 31, 2021 Significant Other Observable Inputs (In millions) Level 1 Level 2 Assets at fair value: Marketable securities $ — $ 86 Derivatives relating to: 1 Foreign currency — 68 Equity securities 2 48 — Total assets at fair value $ 48 $ 154 Liabilities at fair value: Derivatives relating to: 1 Foreign currency — 24 Total liabilities at fair value $ — $ 24 September 30, 2021 Significant Other Observable Inputs (In millions) Level 1 Level 2 Assets at fair value: Marketable securities $ — $ 103 Derivatives relating to: 1 Foreign currency — 57 Equity Securities 2 75 — Total assets at fair value $ 75 $ 160 Liabilities at fair value: Derivatives relating to: 1 Foreign currency — 40 Total liabilities at fair value $ — $ 40 1. See Note 15 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets. 2. The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (322) $ 36 $ 1,257 $ 1,667 Provision for (benefit from) income taxes on continuing operations (74) (28) 372 434 Income (loss) from continuing operations before income taxes (396) 8 1,629 2,101 Depreciation and amortization 310 309 919 926 Interest income (36) (19) (75) (58) Interest expense 18 8 43 22 Exchange (gains) losses 13 (2) 96 47 Non-operating (benefits) costs (9) (315) (134) (941) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges (6) (19) (3) 3 Significant items (benefit) charge 202 (21) 379 214 Corporate expenses 32 40 83 106 Segment operating EBITDA $ 128 $ (11) $ 2,937 $ 2,420
Schedule of Segment Reporting Information, by Segment [Table Text Block]	As of and for the Three Months Ended September 30, (In millions) Seed Crop Protection Total 2022 Net sales $ 862 $ 1,915 $ 2,777 Segment operating EBITDA $ (224) $ 352 $ 128 Segment assets 1 $ 22,665 $ 13,474 $ 36,139 2021 Net sales $ 738 $ 1,633 $ 2,371 Segment operating EBITDA $ (217) $ 206 $ (11) Segment assets 1 $ 23,701 $ 12,539 $ 36,240 1. Segment assets at December 31, 2021 were $23,270 million and $12,428 million for Seed and Crop Protection, respectively. For the Nine Months Ended September 30, (In millions) Seed Crop Protection Total 2022 Net Sales $ 7,333 $ 6,297 $ 13,630 Segment operating EBITDA $ 1,585 $ 1,352 $ 2,937 2021 Net sales $ 7,010 $ 5,166 $ 12,176 Segment operating EBITDA $ 1,523 $ 897 $ 2,420
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Segment assets to total assets (in millions) September 30, 2022 December 31, 2021 September 30, 2021 Total segment assets $ 36,139 $ 35,698 $ 36,240 Corporate assets 4,512 6,646 4,882 Total assets $ 40,651 $ 42,344 $ 41,122
Schedule of Additional Segment Details [Table Text Block]	(In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2022 Restructuring and asset related charges - net 1 $ (66) $ (20) $ (66) $ (152) Estimated settlement expense 2 — (40) — (40) Inventory write-offs 3 (32) — — (32) Gain on sale of business 3 — 15 — 15 Settlement cost associated with Russia Exit 3 (2) — — (2) Employee Retention Credit 6 3 — 9 Total $ (94) $ (42) $ (66) $ (202) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended September 30, 2021 Restructuring and asset related charges - net 1 $ (9) $ (8) $ (9) $ (26) Equity securities mark-to-market gain 47 — — 47 Total $ 38 $ (8) $ (9) $ 21 (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2022 Restructuring and asset related charges - net 1 $ (197) $ (20) $ (83) $ (300) Estimated settlement expense 2 — (57) — (57) Inventory write-offs 3 (33) — — (33) Gain on sale of business 3 — 15 — 15 Loss on exit of non-strategic asset 3 (5) — — (5) Settlement costs associated with Russia Exit 3 (8) — — (8) Employee Retention Credit 6 3 — 9 Total $ (237) $ (59) $ (83) $ (379) (In millions) Seed Crop Protection Corporate Total For the Nine Months Ended September 30, 2021 Restructuring and asset related charges - net 1 $ (145) $ (51) $ (65) $ (261) Equity securities mark-to-market gain 47 — — 47 Total $ (98) $ (51) $ (65) $ (214) 1. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information. 2. Consists of estimated Lorsban® related reserves

EID Segment FN (Tables)

EID Segment FN (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (322) $ 36 $ 1,257 $ 1,667 Provision for (benefit from) income taxes on continuing operations (74) (28) 372 434 Income (loss) from continuing operations before income taxes (396) 8 1,629 2,101 Depreciation and amortization 310 309 919 926 Interest income (36) (19) (75) (58) Interest expense 18 8 43 22 Exchange (gains) losses 13 (2) 96 47 Non-operating (benefits) costs (9) (315) (134) (941) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges (6) (19) (3) 3 Significant items (benefit) charge 202 (21) 379 214 Corporate expenses 32 40 83 106 Segment operating EBITDA $ 128 $ (11) $ 2,937 $ 2,420
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Segment assets to total assets (in millions) September 30, 2022 December 31, 2021 September 30, 2021 Total segment assets $ 36,139 $ 35,698 $ 36,240 Corporate assets 4,512 6,646 4,882 Total assets $ 40,651 $ 42,344 $ 41,122
EID [Member]
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Income (loss) from continuing operations after income taxes $ (333) $ 27 $ 1,232 $ 1,637 Provision for (benefit from) income taxes on continuing operations (77) (30) 364 425 Income (loss) from continuing operations before income taxes (410) (3) 1,596 2,062 Depreciation and amortization 310 309 919 926 Interest income (36) (19) (75) (58) Interest expense 32 19 76 61 Exchange (gains) losses 13 (2) 96 47 Non-operating (benefits) costs (9) (315) (134) (941) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges (6) (19) (3) 3 Significant items (benefit) charge 202 (21) 379 214 Corporate expenses 32 40 83 106 Segment operating EBITDA $ 128 $ (11) $ 2,937 $ 2,420

Summary of Significant Accoun_3

Summary of Significant Accounting Policies Summary of Accounting Policies (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Foreign Exchange Impact on Income (Loss) from Continuing Operations	$ 20
Percentage deterioration of the official Peso to USD exchange rate	10%
Argentina Percentage annual sales and EBITDA	5%

Divestitures and Other Transact

Divestitures and Other Transactions Separation Agreements (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Accounts and Notes Receivable [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Assets	$ 33	$ 25	$ 25
Other Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnification Assets	91	75	70
Accrued and Other Current Liabilities [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnified Liabilities	24	20	54
Other noncurrent obligations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Indemnified Liabilities	$ 122	$ 117	$ 90

Divestitures and Other Transa_2

Divestitures and Other Transactions Other Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income (loss) from discontinued operations after income taxes	$ (6)	$ (4)	$ (46)	$ (59)

Revenue Narrative (Details)

Revenue Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 129	$ 123	$ 122
Minimum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	6 years

Revenue Contract Balances (Deta

Revenue Contract Balances (Details) - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Accounts and notes receivable - trade	[1]	$ 4,875	$ 4,744	$ 3,561
Contract assets - current	[2]	25	24	24
Contract assets - noncurrent	[3]	62	60	58
Deferred Revenue		860	692	3,201
Deferred revenue recognized during the period		3,049	2,454
Accrued and Other Current Liabilities [Member]
Disaggregation of Revenue [Line Items]
Deferred Revenue		860	692	3,201
Other noncurrent obligations
Disaggregation of Revenue [Line Items]
Deferred Revenue	[4]	$ 108	$ 111	$ 120
[1]Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.[2]Included in other current assets in the interim Consolidated Balance Sheets.[3]Included in other assets in the interim Consolidated Balance Sheets.[4]Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue Disaggregation of Reven

Revenue Disaggregation of Revenue - Principal Product Groups (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Net Sales	$ 2,777	$ 2,371	$ 13,630	$ 12,176
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales	862	738	7,333	7,010
Seed [Member] | Corn [Member]
Disaggregation of Revenue [Line Items]
Net Sales	469	437	4,621	4,505
Seed [Member] | Soybean [Member]
Disaggregation of Revenue [Line Items]
Net Sales	205	157	1,685	1,494
Seed [Member] | Other oilseeds [Member]
Disaggregation of Revenue [Line Items]
Net Sales	124	94	647	661
Seed [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	64	50	380	350
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,915	1,633	6,297	5,166
Crop Protection [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	88	96	377	257
Crop Protection [Member] | Herbicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,043	782	3,472	2,737
Crop Protection [Member] | Insecticides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	363	416	1,275	1,261
Crop Protection [Member] | Fungicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 421	$ 339	$ 1,173	$ 911

Revenue Disaggregation of Rev_2

Revenue Disaggregation of Revenue - Geography (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Net Sales		$ 2,777	$ 2,371	$ 13,630	$ 12,176
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales		862	738	7,333	7,010
Seed [Member] | North America
Disaggregation of Revenue [Line Items]
Net Sales	[1]	218	168	4,637	4,482
Seed [Member] | EMEA
Disaggregation of Revenue [Line Items]
Net Sales	[2]	157	153	1,442	1,398
Seed [Member] | Latin America
Disaggregation of Revenue [Line Items]
Net Sales		383	334	912	842
Seed [Member] | Asia Pacific
Disaggregation of Revenue [Line Items]
Net Sales		104	83	342	288
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales		1,915	1,633	6,297	5,166
Crop Protection [Member] | North America
Disaggregation of Revenue [Line Items]
Net Sales	[1]	521	422	2,185	1,693
Crop Protection [Member] | EMEA
Disaggregation of Revenue [Line Items]
Net Sales	[2]	297	237	1,452	1,304
Crop Protection [Member] | Latin America
Disaggregation of Revenue [Line Items]
Net Sales		898	763	1,852	1,361
Crop Protection [Member] | Asia Pacific
Disaggregation of Revenue [Line Items]
Net Sales		$ 199	$ 211	$ 808	$ 808
[1]Represents U.S. & Canada.[2]Europe, Middle East, and Africa ("EMEA").

Restructuring and Asset Relat_3

Restructuring and Asset Related Charges - 2022 Restructuring Actions (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022		Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		$ 152	$ 26	$ 300		$ 261
2022 Restructuring Actions- Russia Exit
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		47		47
2022 Restructuring Actions- Russia Exit | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		20		20
2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				0
Restructuring and Asset related charges, net	[1],[2]	146		202
Payments for Restructuring				(24)
Asset write-offs and adjustments				(70)
Restructuring Reserve, Ending Balance		108		108
2022 Restructuring Actions | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		350		350
Future Cash Payments		150		150
2022 Restructuring Actions | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		420		420
Future Cash Payments		175		175
Exit of non strategic asset | 2022 Restructuring Actions | Other Income
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net				5
Severance and Related Benefit Costs | 2022 Restructuring Actions- Russia Exit
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		6		6
Severance and Related Benefit Costs | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				0
Restructuring and Asset related charges, net		66		88
Payments for Restructuring				(19)
Asset write-offs and adjustments				0
Restructuring Reserve, Ending Balance		69		69
Severance and Related Benefit Costs | 2022 Restructuring Actions | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		105		105
Severance and Related Benefit Costs | 2022 Restructuring Actions | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		120		120
Contract Termination | 2022 Restructuring Actions- Russia Exit
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		28		28
Contract Termination | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	[3]			0
Restructuring and Asset related charges, net	[4]	14		44	[3]
Payments for Restructuring	[3]			(5)
Asset write-offs and adjustments	[3]			0
Restructuring Reserve, Ending Balance	[3]	39		39
Contract Termination | 2022 Restructuring Actions | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		65		65
Contract Termination | 2022 Restructuring Actions | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		80		80
Asset Related Charges [Member] | 2022 Restructuring Actions- Russia Exit
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		3		3
Asset Related Charges [Member] | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				0
Restructuring and Asset related charges, net		66		70
Payments for Restructuring				0
Asset write-offs and adjustments				(70)
Restructuring Reserve, Ending Balance		0		0
Asset Related Charges [Member] | 2022 Restructuring Actions | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		155		155
Asset Related Charges [Member] | 2022 Restructuring Actions | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		180		180
inventory write-offs | 2022 Restructuring Actions- Russia Exit | Cost of Goods Sold
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		2		2
inventory write-offs | 2022 Restructuring Actions | Cost of Goods Sold
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net				33
Other [Member] | 2022 Restructuring Actions | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		25		25
Other [Member] | 2022 Restructuring Actions | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		40		40
Settlement Cost
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		(2)		(8)
Settlement Cost | 2022 Restructuring Actions- Russia Exit | Other Income
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		8		8
Gain on Sale of Business | 2022 Restructuring Actions- Russia Exit | Other Income
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net				15
Seed [Member] | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		61		94
Seed [Member] | Settlement Cost
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		(2)		(8)
Crop Protection [Member] | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		19		20
Corporate Segment | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		$ 66		$ 88
[1]This amount excludes the pre-tax charges impacting Seed recorded to cost of goods sold and other income - net in the company's interim Consolidated Statement of Operations, relating to inventory write-offs of $33 million, and a gain on sale of a business of $15 million, settlement costs associated with the Russia Exit, and charges associated with the exit of a non-strategic asset of $5 million, respectively.[2]This amount excludes the pre-tax charges recorded to the cost of goods sold and other income - net in the interim Consolidated Statement of Operations, relating to inventory write-offs of $33 million, and a gain on sale of a business of $15 million, settlement costs associated with the Russia Exit and charges associated with the exit of a non-strategic asset of $5 million, respectively.[3]The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2022[4]Contract terminations includes early lease terminations.

Restructuring and Asset Relat_4

Restructuring and Asset Related Charges - 2021 Restructuring Activities (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022		Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		$ 152	$ 26	$ 300		$ 261
2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Asset Retirement Obligation		3		3
Restructuring Reserve, Beginning Balance				64
Restructuring and Asset related charges, net		0	17	(1)		127
Payments for Restructuring				(43)
Asset write-offs and adjustments				1
Restructuring Reserve, Ending Balance		21		21
Restructuring and Related Cost, Cost Incurred to Date		166		166
Severance and Related Benefit Costs | 2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				52
Restructuring and Asset related charges, net		0	9	3		58
Payments for Restructuring				(35)
Asset write-offs and adjustments				0
Restructuring Reserve, Ending Balance		20		20
Restructuring and Related Cost, Cost Incurred to Date		77		77
Asset Related Charges [Member] | 2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance	[1]			0
Restructuring and Asset related charges, net		0	7	(1)	[1]	29
Payments for Restructuring	[1]			0
Asset write-offs and adjustments	[1]			1
Restructuring Reserve, Ending Balance	[1]	0		0
Restructuring and Related Cost, Cost Incurred to Date		44		44
Asset Retirement Obligation Costs [Member] | 2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		6		6
Contract Termination | 2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve, Beginning Balance				12
Restructuring and Asset related charges, net		0	1	(3)		40
Payments for Restructuring				(8)
Asset write-offs and adjustments				0
Restructuring Reserve, Ending Balance		1		1
Restructuring and Related Cost, Cost Incurred to Date		39		39
Seed [Member] | 2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		1	4	(1)		21
Crop Protection [Member] | 2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		(1)	4	(3)		41
Corporate Segment | 2021 Restructuring Actions [Domain]
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		$ 0	$ 9	$ 3		$ 65
[1]In addition, the company has a liability recorded for asset retirement obligations of $3 million as of September 30, 2022.

Restructuring and Asset Relat_5

Restructuring and Asset Related Charges Execute to Win Productivity Program (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net	$ 152	$ 26	$ 300	$ 261

Restructuring and Asset Relat_6

Restructuring and Asset Related Charges Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Asset Related [Member]
Restructuring Cost and Reserve [Line Items]
Accelerated Prepaid Royalty Amortization Expense	$ 5	$ 5	$ 104	$ 124

Related Party Transactions Dow

Related Party Transactions Dow Intercompany Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Corteva [Member] | EID [Member]
Related Party Transaction [Line Items]
Interest Expense, Related Party	$ 14	$ 11	$ 33	$ 39

Supplementary Information Other

Supplementary Information Other Income (Expense) - Net (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Interest income		$ 36	$ 19	$ 75	$ 58
Equity in earnings (losses) of affiliates - net		(1)	(1)	13	4
Net gain (loss) on sales of businesses and other assets		16	1	17	2
Net exchange gains (losses)	[1]	(13)	2	(96)	(47)
Non-operating pension and other post employment benefit credit	[2]	22	326	170	979
Miscellaneous expenses - net	[3]	(37)	31	(90)	17
Other income - net		23	378	89	1,013
Hedging Program [Member]
Net exchange gains (losses)		67	34	24	0
Hedging Program [Member] | Argentine Peso Devaluation [Member]
Net exchange gains (losses)		(32)	(16)	(65)	(53)
Subsidiary Monetary Position
Net exchange gains (losses)		(80)	(32)	(120)	(47)
Segment Reconciling Items [Member]
Interest income		(36)	(19)	(75)	(58)
Net exchange gains (losses)		13	(2)	96	47
Non-operating pension and other post employment benefit credit		$ (9)	$ (315)	(134)	$ (941)
Gain (Loss) on Disposition of Assets	[4]			(5)
Segment Reconciling Items [Member] | Seed [Member]
Gain (Loss) on Disposition of Assets				$ (5)
[1]Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively.[2]Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).[3]Miscellaneous income (expenses) - net for the three and nine months ended September 30, 2022 and 2021 includes losses on sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. Miscellaneous income (expenses) - net for the three and nine months ended September 30, 2022 also includes estimated settlement reserves, settlement cost associated with the Russia Exit and an Employee Retention Credit, and the nine months ended September 30, 2022 also includes charges associated with the exit of a non-strategic asset. Additionally, the three and nine months ended September 30, 2021 includes a gain from remeasurement of an equity investment and the nine months ended September 30, 2021 includes realized losses on sale of available-for-sale securities.[4]Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions.

Supplementary Information Forei

Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net	[1]	$ (13)	$ 2	$ (96)	$ (47)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		(55)	(5)	(66)	(11)
Foreign Currency Transaction (Loss) Gain After Tax		(68)	(3)	(162)	(58)
Subsidiary Monetary Position
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net		(80)	(32)	(120)	(47)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		(40)	3	(61)	(11)
Foreign Currency Transaction (Loss) Gain After Tax		(120)	(29)	(181)	(58)
Hedging Program [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net		67	34	24	0
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		(15)	(8)	(5)	0
Foreign Currency Transaction (Loss) Gain After Tax		$ 52	$ 26	$ 19	$ 0
[1]Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively.

Supplementary Information Recon

Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Millions	Sep. 30, 2022		Dec. 31, 2021	Sep. 30, 2021		Dec. 31, 2020
Restricted Cash and Cash Equivalents Items [Line Items]
Cash and cash equivalents	$ 2,199		$ 4,459	$ 2,779
Total Cash, Cash Equivalents and Restricted Cash Equivalents	2,619	[1]	4,836	3,140	[1]	$ 3,873
Other Current Assets [Member]
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted Cash Equivalents	$ 420		$ 377	$ 361
[1]See page 16 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Income Taxes Income Tax Narrati

Income Taxes Income Tax Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Net tax benefits	$ 55	$ 32	$ 39	$ 58
Net Tax Charges	$ 9
Tax Benefit associated with U.S. Research and Development Tax Credits				$ 22

Earnings Per Share Net Income f

Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Income (loss) from continuing operations after income taxes	$ (322)	$ 36	$ 1,257	$ 1,667
Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations	3	2	9	8
Net income (loss) from Continuing Operations Available to Common Shareholders	(325)	34	1,248	1,659
Income (loss) from discontinued operations after income taxes	(6)	(4)	(46)	(59)
Net income (loss) Available to Common Stockholders	$ (331)	$ 30	$ 1,202	$ 1,600

Earnings Per Share Earnings Per

Earnings Per Share Earnings Per Share Calculations - Basic (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Basic earnings (loss) per share of common stock from continuing operations	$ (0.45)	$ 0.05	$ 1.73	$ 2.25
Basic earnings (loss) per share of common stock from discontinued operations	$ (0.01)	$ (0.01)	$ (0.06)	$ (0.08)
Basic earnings (loss) per share of common stock	$ (0.46)	$ 0.04	$ 1.67	$ 2.17

Earnings Per Share Earnings P_2

Earnings Per Share Earnings Per Share Calculations - Diluted (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share [Abstract]
Diluted earnings (loss) per share of common stock from continuing operations	$ (0.45)	$ 0.05	$ 1.72	$ 2.23
Diluted earnings (loss) per share of common stock from discontinued operations	$ (0.01)	$ (0.01)	$ (0.06)	$ (0.08)
Diluted earnings (loss) per share of common stock	$ (0.46)	$ 0.04	$ 1.66	$ 2.15

Earnings Per Share Share Count

Earnings Per Share Share Count Information (Details) - shares		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Earnings Per Share [Line Items]
Weighted Average Common Shares - basic		718,700,000	733,800,000	722,800,000	738,100,000
Dilutive effect of equity compensation plans	[1]	0	5,700,000	3,600,000	5,900,000
Weighted Average Common Shares - diluted		718,700,000	739,500,000	726,400,000	744,000,000
Potential shares of common stock excluded from EPS calculations	[2]	6,100,000	3,000,000	2,200,000	3,100,000
Common Stock, Shares Authorized		1,666,667,000	1,666,667,000	1,666,667,000	1,666,667,000	1,666,667,000
[1]Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.[2]These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable_3

Accounts and Notes Receivable (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable - trade	[1]	$ 3,642	$ 3,336	$ 3,642	$ 3,336	$ 3,441
Notes receivable - trade	[1],[2]	1,233	1,408	1,233	1,408	120
Other	[3]	1,398	1,074	1,398	1,074	1,250
Accounts and notes receivable - net		6,273	5,818	6,273	5,818	4,811
Accounts Receivable, Allowance for Credit Loss, Current		213	210	213	210	210	$ 208
Due from Affiliates		132	84	132	84	104
Factoring Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Trade Receivables Sold		35	70	130	257
Trade receivables sold the remain outstanding with an element of recourse		47	173	47	173	$ 166
Loss on Sale of Accounts Receivable		$ 6	$ 11	$ 19	$ 54
[1]Accounts receivable – trade and notes receivable - trade are net of allowances of $213 million at September 30, 2022, and $210 million at December 31, 2021, and September 30, 2021. Allowances are equal to the estimated uncollectible amounts and are based on the expected credit losses and were developed using a loss-rate method.[2]Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of September 30, 2022, December 31, 2021, and September 30, 2021 there were no significant impairments related to current loan agreements.[3]Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 10 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $132 million, $104 million, and $84 million as of September 30, 2022, December 31, 2021, and September 30, 2021, respectively.

Accounts and Notes Receivable A

Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Receivables [Abstract]
Accounts Receivable, Allowance for Credit Loss, Beginning Balance	$ 210	$ 208
Net Benefit for Credit Losses	4	(7)
Write-offs charged against allowance/ other	(1)	9
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 213	$ 210

Inventories Schedule of Invento

Inventories Schedule of Inventory (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Inventory [Line Items]
Finished Products	$ 2,082	$ 2,497	$ 1,871
Semi-finished Products	2,557	2,076	2,028
Raw Materials and Supplies	776	607	518
Total inventories	$ 5,415	$ 5,180	$ 4,417

Property, Plant and Equipment S

Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 8,444	$ 8,364	$ 8,270
Accumulated Depreciation	$ (4,259)	$ (4,035)	$ (3,960)

Other Intangible Assets Other I

Other Intangible Assets Other Intangible Assets (Details) - USD ($) $ in Millions		3 Months Ended
		Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 12,600	$ 12,516	$ 12,595
Finite-Lived Intangible Assets, Accumulated Amortization		(2,385)	(3,065)	(2,561)
Finite-Lived Intangible Assets, Net		10,215	9,451	10,034
Indefinite-lived Intangible Assets (Excluding Goodwill)		10	10	10
Intangible Assets, Gross (Excluding Goodwill)		12,610	12,526	12,605
Total other intangible assets		10,225	9,461	10,044
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)		54
Impairment of Intangible Assets Indefinite lived Excluding Goodwill After Tax		41
In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)		10	10	10
Germplasm [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		6,265	6,265	6,265
Finite-Lived Intangible Assets, Accumulated Amortization		(507)	(762)	(571)
Finite-Lived Intangible Assets, Net		5,758	5,503	5,694
Customer-Related Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,956	1,890	1,953
Finite-Lived Intangible Assets, Accumulated Amortization		(460)	(550)	(487)
Finite-Lived Intangible Assets, Net		1,496	1,340	1,466
Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,485	1,485	1,485
Finite-Lived Intangible Assets, Accumulated Amortization		(641)	(790)	(679)
Finite-Lived Intangible Assets, Net		844	695	806
Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		2,012	2,006	2,012
Finite-Lived Intangible Assets, Accumulated Amortization		(152)	(231)	(172)
Finite-Lived Intangible Assets, Net		1,860	1,775	1,840
Favorable Supply Contract [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		475	475	475
Finite-Lived Intangible Assets, Accumulated Amortization		(373)	(467)	(396)
Finite-Lived Intangible Assets, Net		102	8	79
Other Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[1]	407	395	405
Finite-Lived Intangible Assets, Accumulated Amortization	[1]	(252)	(265)	(256)
Finite-Lived Intangible Assets, Net	[1]	$ 155	$ 130	$ 149
[1]Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Other Intangible Assets Future

Other Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 178	$ 180	$ 536	$ 543
Continuing Operations [Member]
Finite-Lived Intangible Assets [Line Items]
Pre-tax amortization expense, remainder of 2021	164		164
Pre-tax amortization expense, 2022	616		616
Pre-tax amortization expense, 2023	602		602
Pre-tax amortization expense, 2024	565		565
Pre-tax amortization expense, 2025	554		554
Pre-tax amortization expense, 2026	$ 494		$ 494

Short-Term Borrowings, Long-T_3

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) - USD ($) $ in Millions	Sep. 30, 2022	Feb. 08, 2022	Dec. 31, 2021	Sep. 30, 2021
Short-term Debt [Line Items]
Long-term Debt Payable within one year	$ 0		$ 1	$ 1
Finance Lease, Liability, Current	1		1	1
Short-term borrowings and finance lease obligations	1,576		17	1,372
Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term borrowings	1,369		0	802
Securities Sold under Agreements to Repurchase [Member]
Short-term Debt [Line Items]
Short-term borrowings		$ 500
Other loans - various currencies [Member]
Short-term Debt [Line Items]
Short-term borrowings	6		15	18
Repurchase Agreements [Member] | Securities Sold under Agreements to Repurchase [Member]
Short-term Debt [Line Items]
Short-term borrowings	$ 200		$ 0	$ 550

Short-Term Borrowings, Long-T_4

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2022	May 01, 2022	Dec. 31, 2021	Sep. 30, 2021
Debt Instrument [Line Items]
Long-term Debt Payable within one year	$ 0		$ 1	$ 1
Long-term Debt and Lease Obligation	1,277		1,100	1,101
Finance Lease, Liability, Noncurrent	2		3	3
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	8		10	10
Line of Credit Facility, Maximum Borrowing Capacity	5,500
Line of Credit Facility, Remaining Borrowing Capacity	5,500
Foreign Currency Loans
Debt Instrument [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	85
Revolving Credit Facilities due 2027
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	3,000	$ 3,000
Line of Credit Facility, Remaining Borrowing Capacity	3,000
Revolving Credit Facilities due 2025 [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	2,000	2,000
Line of Credit Facility, Remaining Borrowing Capacity	2,000
364-day Revolving Credit Facilities due 2023
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	500	$ 500
Line of Credit Facility, Remaining Borrowing Capacity	500
Medium-term Notes [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 107		$ 107	$ 108
Long-term Debt, Weighted Average Interest Rate, at Point in Time	2.87%		0%	0%
Loans Payable [Member] | Notes Maturing 2025 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500		$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	1.70%		1.70%	1.70%
Loans Payable [Member] | Notes Maturing 2030 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500		$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	2.30%		2.30%	2.30%
Loans Payable [Member] | Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 176		$ 1	$ 1
Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	14.80%		6.82%	6.38%
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 1,154		$ 1,121	$ 1,134

Short-Term Borrowings, Long-T_5

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) $ in Millions	9 Months Ended		12 Months Ended	37 Months Ended	61 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	May 01, 2023	May 30, 2025	May 31, 2027	May 01, 2022 USD ($)	Feb. 08, 2022 USD ($)	Dec. 31, 2021 USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 5,500
Line of Credit Facility, Maximum Borrowing Capacity	5,500
Proceeds from debt	1,335	$ 419
Repayments of Long-term Debt	355	1
Foreign Currency Loans
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	85
Revolving Credit Facilities due 2022
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity						$ 3,000
Debt Instrument, Term				3 years
Revolving Credit Facilities due 2024 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term					5 years
Revolving Credit Facilities due 2025 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	2,000
Line of Credit Facility, Maximum Borrowing Capacity	2,000					2,000
Debt Instrument, Term				3 years
Revolving Credit Facilities due 2025 [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR				0.10%
Revolving Credit Facilities due 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	3,000
Line of Credit Facility, Maximum Borrowing Capacity	3,000					$ 3,000
Debt Instrument, Term					5 years
Revolving Credit Facility
Line of Credit Facility [Line Items]
Ratio of Indebtedness to Net Capital						0.60
364-day Revolving Credit Facilities due 2023
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	500
Line of Credit Facility, Maximum Borrowing Capacity	500					$ 500
Debt Instrument, Term			364 days
Ratio of Indebtedness to Net Capital						0.60
364-day Revolving Credit Facilities due 2023 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR			0.10%
Securities Sold under Agreements to Repurchase [Member]
Line of Credit Facility [Line Items]
Short-term borrowings							$ 500
Percentage of outstanding amounts borrowed utilized as collateral							105%
Securities Sold under Agreements to Repurchase [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR				0.10%
Securities Sold under Agreements to Repurchase [Member] | Repurchase Agreements [Member]
Line of Credit Facility [Line Items]
Short-term borrowings	$ 200	$ 550						$ 0

Commitments and Contingent Li_3

Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 79	$ 105	$ 107
Factoring Agreement [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	19	21	22
Agreements with lenders to provide financing for select customers [Member]
Guarantor Obligations [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 560	$ 15	$ 615

Commitments and Contingent Li_4

Commitments and Contingent Liabilities Chemours (Details) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Jun. 30, 2019 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Mar. 31, 2030 USD ($)	Dec. 31, 2028 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2018 lawsuits
Performance Chemicals
Loss Contingencies [Line Items]
Income (loss) from discontinued operations before income taxes	$ 5	$ 8		$ 32	$ 45
PFAS [Member]
Loss Contingencies [Line Items]
Escrow Account Balance							$ 700
PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Cost Sharing Arrangement Term				20 years
Qualified Spend and Escrow Account Contribution Threshold	4,000			$ 4,000
Corteva and DuPont stray liability threshold for PFAS	300			300
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party			$ 670.7
Lawsuits alleging personal injury filed | lawsuits									3,550
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Amount credited to each company's threshold	$ 150			$ 150
Chemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Annual Escrow Deposit								$ 100
Annual Escrow Deposit, remainder of period						$ 50
Chemours [Member] | PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Total Escrow Deposit Amount						500
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29%			29%
Corteva [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%			50%
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%			50%
Annual Escrow Deposit								$ 100
Annual Escrow Deposit, remainder of period						50
Escrow Account Deposit Percentage	50%			50%
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold	$ 2,000			$ 2,000
Total Escrow Deposit Amount						$ 500
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71%			71%
DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%			50%
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	$ 200			$ 200

Commitments and Contingent Li_5

Commitments and Contingent Liabilities DuPont (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Accounts and Notes Receivable [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 33,000,000	$ 25,000,000	$ 25,000,000
Other Assets [Member]
Loss Contingencies [Line Items]
Indemnification Assets	91,000,000	75,000,000	70,000,000
Accrued and Other Current Liabilities [Member]
Loss Contingencies [Line Items]
Indemnified Liabilities	24,000,000	20,000,000	54,000,000
Other noncurrent obligations
Loss Contingencies [Line Items]
Indemnified Liabilities	122,000,000	$ 117,000,000	$ 90,000,000
PFAS [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	1
PFAS [Member] | Minimum [Member] | Once $300 million threshold is met [Member]
Loss Contingencies [Line Items]
De minimis threshold	1,000,000
PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	300,000,000
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Amount credited to each company's threshold	150,000,000
Litigation Settlement [Abstract]
Escrow Balance	$ 125,000,000
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29%
Corteva [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
Corteva [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71%
DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Corteva and DuPont stray liability threshold for PFAS	$ 200,000,000

Commitments and Contingent Li_6

Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)	3 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2019 USD ($)	Sep. 30, 2022 USD ($) lawsuits	Dec. 31, 2004 USD ($)	Dec. 31, 2018 lawsuits	Jan. 01, 2012
MDL Settlement [Domain]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 83,000,000
DuPont de Nemours and Corteva Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		27,000,000
Payments for Legal Settlements		27,000,000
PFAS [Member] | Chemours [Member]
Loss Contingencies [Line Items]
Chemours Contribution to MDL Settlement		0.50
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding Settlement Agreement Class Size			80,000
Loss Contingency, Number Of Water Districts Receiving Water Treatment					6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold			$ 235,000,000
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date		2,000,000
Escrow Balance		$ 1,000,000
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Settled Litigation
Loss Contingencies [Line Items]
Loss Contingency, Claims Settled, Number | lawsuits		95,000,000
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Compensatory damages [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 40,000,000
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Loss of consortium [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 10,000,000
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Disease Categories for MDL		6
Lawsuits alleging personal injury filed | lawsuits				3,550
Litigation Settlement, Amount Awarded to Other Party	$ 670,700,000

Commitments and Contingent Li_7

Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) lawsuits
Loss Contingencies [Line Items]
Loss Contingency, Number of Defendants | lawsuits		30
DELAWARE
Loss Contingencies [Line Items]
Income (loss) from discontinued operations before income taxes	$ 11
Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits		3,100
Personal injury cases [Member] | Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number		2,800
Municipal water districts | Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number		230
Chemours Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 29
NEW YORK | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number		45
NEW JERSEY | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits		2
NEW JERSEY | Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number		4
OHIO | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits		3
NORTH CAROLINA | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Property Owners		100
Loss Contingency, Number of Additional Plaintiffs		100
DELAWARE | Natural Resources Damages [Member] | Corteva [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Threshold for payments to fund the NRST Trust		$ 50
Supplemental payment threshold		$ 25
Period for supplemental payment		8 years
Corteva and DuPont Share of NRST Trust Payment		$ 12.5
DELAWARE | Natural Resources Damages [Member] | Chemours [Member]
Loss Contingencies [Line Items]
Chemours share of payment to NRST Trust		$ 25
Chemours share of payment to NRST Trust, percentage		50%
NETHERLANDS | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits		4
Alabama Water Utility [Member] | Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number		1

Commitments and Contingent Li_8

Commitments and Contingent Liabilities Environmental (Details) - USD ($) $ in Millions		Sep. 30, 2022	Jan. 28, 2022
Loss Contingencies [Line Items]
Indemnification Asset		$ 245
Accrual for Environmental Loss Contingencies	[1]	483
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1]	596
Non-PFAS
Loss Contingencies [Line Items]
Request for Remediation Funding Source ("RFS")			$ 900
Chemours related obligation subject to indemnification [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[2],[3]	155
Accrual for Environmental Loss Contingencies	[1],[2],[3]	155
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[2],[3]	266
Discontinued Operations [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[2]	24
Other discontinued or divested business obligations [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	[1],[2]	77
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[2]	185
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[3]	45
Accrual for Environmental Loss Contingencies	[1],[3]	46
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[3]	62
Not subject to indemnification [Member]
Loss Contingencies [Line Items]
Indemnification Asset		0
Accrual for Environmental Loss Contingencies	[1]	80
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1]	54
Indemnification liabilities related to the MOU
Loss Contingencies [Line Items]
Indemnification Asset	[4]	21
Accrual for Environmental Loss Contingencies	[1],[4]	125
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[2],[4]	29
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold		200
Superfund Sites [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies		67
Superfund Sites [Member] | Chemours [Member] | Indemnification Agreement [Member]
Loss Contingencies [Line Items]
Indemnification Asset		$ 36
[1]Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balances includes $67 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 28 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the NC DEQ. 4. Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."

Stockholders' Equity Common Sto

Stockholders' Equity Common Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Oct. 28, 2022	Sep. 13, 2022	Dec. 31, 2021	Aug. 05, 2021	Jun. 26, 2019
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.01		$ 0.01
Repurchase of Common Stock			$ 800	$ 750
2019 Share Buyback Plan
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares		3,408		15,378
Stock Repurchase Program, Authorized Amount									$ 1,000
Repurchase of Common Stock		$ 150		$ 700
2021 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares	3,414		14,284
Stock Repurchase Program, Authorized Amount								$ 1,500
Repurchase of Common Stock	$ 200		$ 800
2022 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount						$ 2,000
Corteva [Member]
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01		$ 0.01						$ 0.01

Stockholders' Equity Preferred

Stockholders' Equity Preferred Stock (Details) - EID [Member] - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
$4.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
$3.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102
Corteva [Member]
Class of Stock [Line Items]
Ownership interest in an entity	100%

Stockholders' Equity Other Comp

Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions		3 Months Ended								9 Months Ended
		Sep. 30, 2022		Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021		Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance					$ (2,898)					$ (2,898)
Beginning Balance		$ 26,071		$ 25,936	25,623	$ 25,625		$ 24,778	$ 25,063	25,623	$ 25,063
Amounts Reclassified from Accumulated Other Comprehensive Loss		48				(141)				(28)	(444)
Other comprehensive (loss) income		(369)		(402)	77	(400)		122	(477)	(694)	(755)
Ending Balance		25,084		26,071	25,936	24,979		25,625	24,778	25,084	24,979
Ending Balance		(3,592)				(3,645)				(3,592)	(3,645)
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance					(396)				(1,433)	(396)	(1,433)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax										107	(6)
Amounts Reclassified from Accumulated Other Comprehensive Loss										21	32
Other comprehensive (loss) income										128	26
Ending Balance		(268)				(1,407)				(268)	(1,407)
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance					(31)				590	(31)	590
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax										3	1
Amounts Reclassified from Accumulated Other Comprehensive Loss										1	(475)
Other comprehensive (loss) income										4	(474)
Ending Balance		(27)				116				(27)	116
Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance					(2,543)				(1,970)	(2,543)	(1,970)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax	[1]									(868)	(424)
Amounts Reclassified from Accumulated Other Comprehensive Loss										0	0
Other comprehensive (loss) income										(868)	(424)
Ending Balance		(3,411)				(2,394)				(3,411)	(2,394)
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance					72				(67)	72	(67)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax										92	115
Amounts Reclassified from Accumulated Other Comprehensive Loss		28				5				(50)	(8)
Other comprehensive (loss) income										42	107
Ending Balance		114				40				114	40
Unrealized Gain (loss) on Investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance					0				(10)	0	(10)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax										0	3
Amounts Reclassified from Accumulated Other Comprehensive Loss		0	[2]			0	[2]			0	7
Other comprehensive (loss) income										0	10
Ending Balance		0				0				0	0
Total
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance					(2,898)				(2,890)	(2,898)	(2,890)
Beginning Balance		(3,223)		(2,821)	(2,898)	(3,245)		(3,367)	(2,890)	(2,898)	(2,890)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax										(666)	(311)
Amounts Reclassified from Accumulated Other Comprehensive Loss										(28)	(444)
Other comprehensive (loss) income		(369)		(402)	77	(400)		122	(477)	(694)	(755)
Ending Balance		(3,592)		$ (3,223)	$ (2,821)	(3,645)		$ (3,245)	$ (3,367)	(3,592)	(3,645)
Ending Balance		$ (3,592)				$ (3,645)				$ (3,592)	$ (3,645)
[1]The cumulative translation adjustment gain for the nine months ended September 30, 2022 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF"), Indian Rupee ("INR") and South African Rand ("ZAR"). The cumulative translation adjustment loss for the nine months ended September 30, 2021 was primarily driven by strengthening of the USD against the European Euro ("EUR"), Swiss Franc ("CHF") and Brazilian Real ("BRL").[2]Reflected in other income - net in the interim Consolidated Statements of Operations.

Stockholders' Equity Tax Benefi

Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ (43)	$ 36	$ (45)	$ 103
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	(30)	(3)	(35)	(8)
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	0	51	3	148
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ (13)	$ (12)	$ (13)	$ (37)

Stockholders' Equity Reclassifi

Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended				9 Months Ended
		Sep. 30, 2022		Sep. 30, 2021		Sep. 30, 2022	Sep. 30, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss		$ 48		$ (141)		$ (28)	$ (444)
Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amortization of Prior Service Benefit		0	[1],[2]	(231)	[1],[2]	(1)	(692)
Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss						21	32
Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss						1	(475)
Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		33	[3]	6	[3]	(68)	(9)
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax		(5)	[4]	(1)	[4]	18	1
Amounts Reclassified from Accumulated Other Comprehensive Loss		28		5		(50)	(8)
Actuarial (Gains) Losses | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		0	[1],[2]	14	[1],[2]	2	41
Actuarial (Gains) Losses | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		1	[1],[2]	23	[1],[2]	2	70
Settlement Loss | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		25	[1],[2]	0	[1],[2]	27	1
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		25		14		27	41
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax		(6)	[4]	(3)	[4]	(6)	(9)
Amounts Reclassified from Accumulated Other Comprehensive Loss		19		11		21	32
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		1		(208)		1	(623)
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax		0	[4]	51	[4]	0	148
Amounts Reclassified from Accumulated Other Comprehensive Loss		1		(157)		1	(475)
Unrealized loss on investments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax		0	[4]	0	[4]	0	0
Amounts Reclassified from Accumulated Other Comprehensive Loss		0	[1]	0	[1]	0	7
Prior Service Benefit | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[1],[2]	0		0		(2)	(1)
Accumulated Defined Benefit Plans Adjustment, Curtailment Gain (Loss) | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		$ 0		$ 0		$ 0	$ (1)
[1]Reflected in other income - net in the interim Consolidated Statements of Operations.[2]These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 14 - Pension Plans and Other Post Employment Benefits, for additional information.[3]Reflected in cost of goods sold in the interim Consolidated Statements of Operations.[4]Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations.

Pension Plans and Other Post _3

Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	$ 5	$ 7	$ 14	$ 19
Interest Cost	126	91	343	273
Expected return on plan assets	(180)	(228)	(560)	(686)
Amortization of unrecognized loss (gain)	0	14	2	41
Amortization of Prior Service Benefit	0	0	(2)	(1)
Settlement Loss (Gain)	25	0	27	1
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	(24)	(116)	(176)	(353)
Other Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	0	1	1	1
Interest Cost	6	5	19	16
Amortization of unrecognized loss (gain)	1	23	2	70
Amortization of Prior Service Benefit	0	(231)	(1)	(692)
Curtailment (gain) loss	0	0	0	(1)
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	$ 7	$ (202)	$ 21	$ (606)

Pension Plans and Other Post _4

Pension Plans and Other Post Employment Benefit Plans- Annuity (Details) - Pension Plan - USD ($) $ in Millions		3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan	$ 1,100
Settlement Gain (Loss)		$ 25	$ 0	$ 27	$ 1
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate				4.60%		2.82%
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)		$ 110

Financial Instruments Financial

Financial Instruments Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Cash Equivalents [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 921	$ 3,400	$ 2,108
Marketable Securities [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	119	$ 86	$ 103
Other Assets [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 24

Financial Instruments Notional

Financial Instruments Notional Amounts (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 948	$ 1,252	$ 1,227
Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,424	845	262
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,371	103	1,164
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 3	$ 4	$ 7

Financial Instruments Cash Flow

Financial Instruments Cash Flow Hedges Included in AOCI (Details) € in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 EUR (€)	Dec. 31, 2021 USD ($)
Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity			2 years
Beginning Balance	$ 81	$ 73	$ 47	$ (16)
Additions and revaluations of derivatives designated as cash flow hedges	(25)	(10)	91	93
Clearance of hedge results to earnings	(4)	(4)	(86)	(18)
Ending Balance	52	59	52	59
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			50
Derivative, Notional Amount	1,424	262	$ 1,424	262		$ 845
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity			2 years
Beginning Balance	(31)	(21)	$ 32	(17)
Additions and revaluations of derivatives designated as cash flow hedges	11	8	(56)	3
Clearance of hedge results to earnings	32	9	36	10
Ending Balance	12	(4)	12	(4)
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months			8
Derivative, Notional Amount	$ 948	$ 1,227	$ 948	$ 1,227		$ 1,252
Net Investment Hedging [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount | €					€ 450

Financial Instruments Fair Valu

Financial Instruments Fair Value of Derivatives (Details) - USD ($) $ in Millions		Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		$ 216	$ 71	$ 57
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	(58)	(20)	(23)
Derivative Asset, Net		158	51	34
Derivative Liability, Gross		65	26	40
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	(58)	(20)	(23)
Derivative Liability, Net		7	6	17
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		101	37	20
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	0	0	0
Derivative Asset, Net		101	37	20
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Counterparty and Cash Collateral Netting	[1]			0
Derivative Liability, Gross			1	9
Derivative Liability, Counterparty and Cash Collateral Netting	[1]		0
Derivative Liability, Net			1	9
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross		2
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	0
Derivative Liability, Net		2
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		112	31	37
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	(58)	(20)	(23)
Derivative Asset, Net		54	11	14
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross		63	23	31
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	(58)	(20)	(23)
Derivative Liability, Net		5	3	$ 8
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		3	3
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	0	0
Derivative Asset, Net		$ 3	3
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross			2
Derivative Liability, Counterparty and Cash Collateral Netting	[1]		0
Derivative Liability, Net			$ 2
[1]Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Financial Instruments Effect of

Financial Instruments Effect of Derivative Instruments (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Derivative Instruments, Net, Pretax	[1]	$ 43	$ 39	$ 70	$ (25)
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (loss) gain recognized in OCI- Pre Tax	[2]	30	17	123	153
Amount of gain (loss) recognized in Income - Pre-tax	[1]	(33)	(6)	68	9
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (loss) gain recognized in OCI- Pre Tax	[2]	47	10	74	24
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (loss) gain recognized in OCI- Pre Tax	[2]	13	18	(68)	12
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in Income - Pre-tax	[1],[3]	(39)	(10)	(44)	(11)
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of (loss) gain recognized in OCI- Pre Tax	[2]	(30)	(11)	117	117
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in Income - Pre-tax	[1],[3]	6	4	112	20
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1]	76	45	2	(34)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1],[3]	4	12	(1)	(16)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income - net
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1],[4]	67	34	24	0
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1],[3]	$ 5	$ (1)	$ (21)	$ (18)
[1]For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.[2]OCI is defined as other comprehensive income (loss).[3]Recorded in cost of goods sold in the interim Consolidated Statements of Operations.[4]Gain recognized in other income - net was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 5 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information.

Financial Instruments- AFS Inve

Financial Instruments- AFS Investing Results (Details) - Available-for-sale Securities $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($)
Debt Securities, Available-for-sale [Line Items]
Proceeds from sales of available-for-sale securities	$ 226
Gross realized losses	$ (7)

Financial Instruments Contractu

Financial Instruments Contractual Maturities (Details) $ in Millions	Sep. 30, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Amortized Cost, Within One Year	$ 86
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after Five Through Ten Years, Amortized Cost	24
Fair Value, Within One Year	86
Fair Value, one to five years	$ 24

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions		Sep. 30, 2022	Dec. 31, 2021		Sep. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset		$ 216	$ 71		$ 57
Derivative Liability		65	26		40
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities		0	0		0
Equity Securities,			48	[1]	75
Assets at Fair Value		0	48		75
Liabilities at Fair Value		0	0		0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Foreign Currency Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	[2]	0	0		0
Derivative Liability	[2]	0	0		0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	[2]	0
Derivative Liability	[2]	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities		119	86		103
Equity Securities,			0	[1]	0
Assets at Fair Value		335	154		160
Liabilities at Fair Value		65	24		40
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Currency Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	[2]	213	68		57
Derivative Liability	[2]	63	$ 24		$ 40
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	[2]	3
Derivative Liability	[2]	$ 2
[1]The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.[2]See Note 15 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

Segment Reporting Segment Infor

Segment Reporting Segment Information (Details) - USD ($) $ in Millions		3 Months Ended				9 Months Ended
		Sep. 30, 2022		Sep. 30, 2021		Sep. 30, 2022		Sep. 30, 2021		Dec. 31, 2021
Segment Reporting Information [Line Items]
Net Sales		$ 2,777		$ 2,371		$ 13,630		$ 12,176
Segment operating EBITDA		128		(11)		2,937		2,420
Segment Assets		36,139		36,240		36,139		36,240		$ 35,698
Net exchange gains (losses)	[1]	(13)		2		(96)		(47)
Income from continuing operations before income taxes		(396)		8		1,629		2,101
Interest Expense		18		8		43		22
Interest income		36		19		75		58
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges				(27)
Significant Items		202		(21)		379		214
Corporate Expenses		32		40		83		106
EID [Member]
Segment Reporting Information [Line Items]
Net Sales		2,777		2,371		13,630		12,176
Segment operating EBITDA		128		(11)		2,937		2,420
Income from continuing operations before income taxes		(410)		(3)		1,596		2,062
Interest Expense		32		19		76		61
Depreciation and Amortization		310		309		919		926
Non-operating benefits - net		(9)		(315)		(134)		(941)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		(6)		(19)		(3)		3
Significant Items		202		(21)		379		214
Corporate Expenses		32		40		83		106
Seed [Member]
Segment Reporting Information [Line Items]
Net Sales		862		738		7,333		7,010
Segment operating EBITDA		(224)		(217)		1,585		1,523
Segment Assets		22,665	[2]	23,701	[2]	22,665	[2]	23,701	[2]	23,270
Crop Protection [Member]
Segment Reporting Information [Line Items]
Net Sales		1,915		1,633		6,297		5,166
Segment operating EBITDA		352		206		1,352		897
Segment Assets		13,474	[2]	12,539	[2]	13,474	[2]	12,539	[2]	$ 12,428
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Net exchange gains (losses)		13		(2)		96		47
Depreciation and Amortization		310		309		919		926
Interest income		(36)		(19)		(75)		(58)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		(6)		(19)		(3)		3
Significant Items		(202)		21		(379)		(214)
Segment Reconciling Items [Member] | EID [Member]
Segment Reporting Information [Line Items]
Net exchange gains (losses)		13		(2)		96		47
Interest income		(36)		(19)		(75)		(58)
Segment Reconciling Items [Member] | Seed [Member]
Segment Reporting Information [Line Items]
Significant Items		(94)		38		(237)		(98)
Segment Reconciling Items [Member] | Crop Protection [Member]
Segment Reporting Information [Line Items]
Significant Items		$ (42)		$ (8)		$ (59)		$ (51)
[1]Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively.[2]Segment assets at December 31, 2021 were $23,270 million and $12,428 million for Seed and Crop Protection, respectively.

Segment Reporting Segment Recon

Segment Reporting Segment Reconciliation (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Income (loss) from continuing operations after income taxes		$ (322)	$ 36	$ 1,257	$ 1,667
Provision for (benefit from) income taxes on continuing operations		(74)	(28)	372	434
Income from continuing operations before income taxes		(396)	8	1,629	2,101
Interest income		36	19	75	58
Interest Expense		18	8	43	22
Exchange (gains) losses - net	[1]	(13)	2	(96)	(47)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges			27
Significant Items		202	(21)	379	214
Corporate Expenses		32	40	83	106
Segment operating EBITDA		128	(11)	2,937	2,420
Non-operating pension and other post employment benefit credit	[2]	22	326	170	979
EID [Member]
Segment Reporting Information [Line Items]
Provision for (benefit from) income taxes on continuing operations		(77)	(30)	364	425
Income from continuing operations before income taxes		(410)	(3)	1,596	2,062
Depreciation and Amortization		310	309	919	926
Interest Expense		32	19	76	61
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		6	19	3	(3)
Significant Items		202	(21)	379	214
Corporate Expenses		32	40	83	106
Segment operating EBITDA		128	(11)	2,937	2,420
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		310	309	919	926
Interest income		(36)	(19)	(75)	(58)
Exchange (gains) losses - net		13	(2)	96	47
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		6	19	3	(3)
Significant Items		(202)	21	(379)	(214)
Non-operating pension and other post employment benefit credit		(9)	(315)	(134)	(941)
Segment Reconciling Items [Member] | EID [Member]
Segment Reporting Information [Line Items]
Interest income		(36)	(19)	(75)	(58)
Exchange (gains) losses - net		$ 13	$ (2)	$ 96	$ 47
[1]Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively.[2]Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).

Segment Reporting Segment Asset

Segment Reporting Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
Segment Reporting [Abstract]
Segment Assets	$ 36,139	$ 35,698	$ 36,240
Corporate Assets	4,512	6,646	4,882
Total Assets	$ 40,651	$ 42,344	$ 41,122

Segment Reporting Significant I

Segment Reporting Significant Items (Details) - USD ($) $ in Millions		3 Months Ended				9 Months Ended
		Sep. 30, 2022		Sep. 30, 2021		Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		$ 152		$ 26		$ 300	$ 261
Significant Items		202		(21)		379	214
Net exchange gains (losses)	[1]	(13)		2		(96)	(47)
Settlement Cost
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		(2)				(8)
Settlement Cost | Seed [Member]
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		(2)				(8)
Hedging Program [Member]
Segment Reporting Information [Line Items]
Net exchange gains (losses)		67		34		24	0
Argentine Peso Devaluation [Member] | Hedging Program [Member]
Segment Reporting Information [Line Items]
Net exchange gains (losses)		(32)		(16)		(65)	(53)
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		(152)	[2]	(26)	[2]	(300)	(261)
Inventory Write-down		(32)				(33)
Gain (Loss) on Disposition of Business		15				15
Litigation Settlement, Expense		(40)				(57)
Loss on Divestiture	[3]					(5)
Significant Items		(202)		21		(379)	(214)
Net exchange gains (losses)		13		(2)		96	47
Equity Securities Mark-to-Mark Gain				47			47
Employee Retention Credit		9
Segment Reconciling Items [Member] | Seed [Member]
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		(66)	[2]	(9)	[2]	(197)	(145)
Inventory Write-down		(32)				(33)
Loss on Divestiture						(5)
Significant Items		(94)		38		(237)	(98)
Equity Securities Mark-to-Mark Gain				47			47
Employee Retention Credit		6				6
Segment Reconciling Items [Member] | Crop Protection [Member]
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		(20)	[2]	(8)	[2]	(20)	(51)
Gain (Loss) on Disposition of Business		15				15
Litigation Settlement, Expense		(40)				(57)
Significant Items		(42)		(8)		(59)	(51)
Employee Retention Credit		3				3
Segment Reconciling Items [Member] | Corporate
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		(66)	[2]	(9)	[2]	(83)	(65)
Significant Items		$ (66)		$ (9)		$ (83)	$ (65)
[1]Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively.[2]Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information. 2. Consists of estimated Lorsban® related reserves 3. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions.

EID - Basis of Presentation Nar

EID - Basis of Presentation Narrative (Details) - $ / shares	9 Months Ended
	Sep. 30, 2022	Oct. 28, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 26, 2019
EID [Member]
Common Stock, Shares, Outstanding	200		200	200
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30	$ 0.30
Common Stock, Shares, Outstanding	716,225,000		726,527,000	730,267,000
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Corteva [Member] | EID [Member]
Ownership interest in an entity	100%
Corteva [Member]
Common Stock, Par Value	$ 0.01				$ 0.01

EID - Related Party Transacti_2

EID - Related Party Transactions (Details) - EID [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Related Party Transaction [Line Items]
Long Term Debt - Related Party	$ 1,066	$ 2,443	$ 1,066	$ 2,443	$ 2,162
Corteva [Member]
Related Party Transaction [Line Items]
Debt, Weighted Average Interest Rate	4.12%	1.52%	4.12%	1.52%	1.67%
Interest Expense, Related Party	$ 14	$ 11	$ 33	$ 39
Accrued and Other Current Liabilities [Member] | Corteva [Member]
Related Party Transaction [Line Items]
CTVA Related Party Liability	24	61	24	61	$ 27
Other noncurrent obligations | Corteva [Member]
Related Party Transaction [Line Items]
CTVA Related Party Liability	$ 122	$ 90	$ 122	$ 90	$ 117

EID Segment FN Segment reconcil

EID Segment FN Segment reconciliation (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Provision for (benefit from) income taxes on continuing operations		$ (74)	$ (28)	$ 372	$ 434
Income from continuing operations before income taxes		(396)	8	1,629	2,101
Interest income		36	19	75	58
Interest Expense		18	8	43	22
Exchange (gains) losses - net	[1]	(13)	2	(96)	(47)
Significant Items		202	(21)	379	214
Corporate Expenses		32	40	83	106
Segment operating EBITDA		128	(11)	2,937	2,420
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges			27
EID [Member]
Segment Reporting Information [Line Items]
Income from Continuing Operations After Taxes		(333)	27	1,232	1,637
Provision for (benefit from) income taxes on continuing operations		(77)	(30)	364	425
Income from continuing operations before income taxes		(410)	(3)	1,596	2,062
Depreciation and Amortization		310	309	919	926
Interest Expense		32	19	76	61
Non-operating benefits - net		(9)	(315)	(134)	(941)
Significant Items		202	(21)	379	214
Corporate Expenses		32	40	83	106
Segment operating EBITDA		128	(11)	2,937	2,420
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		6	19	3	(3)
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		310	309	919	926
Interest income		(36)	(19)	(75)	(58)
Exchange (gains) losses - net		13	(2)	96	47
Significant Items		(202)	21	(379)	(214)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		6	19	3	(3)
Segment Reconciling Items [Member] | EID [Member]
Segment Reporting Information [Line Items]
Interest income		(36)	(19)	(75)	(58)
Exchange (gains) losses - net		13	(2)	96	47
Corporate | Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Significant Items		(66)	(9)	(83)	(65)
Crop Protection [Member]
Segment Reporting Information [Line Items]
Segment operating EBITDA		352	206	1,352	897
Crop Protection [Member] | Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Significant Items		$ (42)	$ (8)	$ (59)	$ (51)
[1]Includes net pre-tax exchange gains (losses) of $(32) million and $(65) million associated with the devaluation of the Argentine peso for the three and nine months ended September 30, 2022, respectively, and $(16) million and $(53) million for the three and nine months ended September 30, 2021, respectively.

EID Segment FN Segment Asset Re

EID Segment FN Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021
EID [Member]
Segment Reporting Information [Line Items]
Total Assets	$ 40,651	$ 42,344	$ 41,122
Segment Assets	36,139	35,698	36,240
Corporate Assets	4,512	6,646	4,882
Total Assets	$ 40,651	$ 42,344	$ 41,122